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CHAPTER I
INTRODUCTION
Mammalian embryos undergo a transitional sequence of biologic
developmental changes during the first week of pregnancy, which include
cleavage, compaction, blastocoele formation, and hatching from the zona
pellucida. Unlike species such as rodents and primates, which immediately
implant after hatching, a prolonged pre-implantation period occurs in domestic
farm animals (Stroband and Van der Lende, 1990). Following hatching from the
zona pellucida, the porcine conceptus continues a period of rapid growth and
development in preparation for expansion of its extraembryonic membranes. The
porcine conceptus undertakes an incredible alteration in morphology during the
second week of gestation. This dynamic period is the time accounting for
seventy-five percent of embryonic loss that can occur during the first thirty days
after fertilization. Therefore, the most critical period for conceptus survival is
between days 12 and 18 of pregnancy (Day et a!., 1959; Perry and Rowlands,
1962; Pope, 1994). Since conceptus trophoblastic elongation, attachment, and
placentation occur during the time of greatest embryonic mortality, it is essential
that we thoroughly understand the biology of conceptus-maternal interactions
necessary for estab'lishment of pregnancy in swine. Efforts made to understand
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the integrated system of porcine embryogenesis and implantation are currently
underway in attempt to hopefully alleviate early conceptus death in the future.
The following review of literature will cover developmental events that occur
during the second week of pregnancy in the pig that include: late peri-
implantation conceptus development and elongation, factors contributing to
estrogen production from the conceptus, effects of estrogen on uterine secretion
and maintenance of the corpora lutea, early conceptus mortality, and endometrial
changes essential for conceptus survival. Finally, the kallikrein-kininogen-kinin
system and it relationship to reproductive processes will be reviewed.
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CHAPTER II
LITERATURE REVIEW
Late Peri-Implantation Conceptus Development, Estradiol-17J3 Synthesis
and Elongation
As the porcine conceptus achieves a spherical diameter of 4~ mm,
enzymes essential for conversion of uterine lumenal steroid precursors to
estradiol-17~ (E2) are present (Gadsby et aI., 1980; Fischer et aI., 1985;
Mondschein et al. r 1985; Pusateri et aI., 1990; Conley et aL, 1992, Ko et aI.,
1994), Two enzymes of particular importance are 17a.-hydroxylase (17a.-OH), for
conversion of progesterone to 17a.-hydroxyprogesterone, and aromatase, for
conversion of testos~erone to E2. Seventeen-a.-hydroxylase, expressed only in
the trophectoderm, is the rate-limiting steroidogenic enzyme needed for E2
production (Conley et al., 1992, Wilson'and Ford, 1997), whereas aromatase is
expressed in the inner cell layer (hypoblast) of the trophoblast (Ko et aI., 1994).
The conceptus continues to expand into a large spherical (10 mm) shape
through a mitotic increase in trophectodermal cells. Estradiol production by the
porcine conceptus increases with the increase in trophectodermal cell number.
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Twenty-four hours after the initiation of E2 synthesis (5 mm spherical
conceptus), the conceptuses will expand to a 10 mm in diameter with the
trophectoderm cells displaying a typical cuboidal morphology (Anderson, 1978;
Geisert et aI., 1982a; Mattson et aI., 1990). A sharp increase in conceptus
estrogen secretion occurs on day 11-12 (10 mm spherical conceptuses) with
increased E2 concentrations also detectable in the uterine vein and lymph
(Magness and Ford, 1982). This increase in E2 is correlated with an increase in
blood flow (Ford and Christenson, 1979; Ford et aI., 1982b; Ford, 1983),
alterations in endometrial secretion (Corner, 1921), and is responsible for the
signal for the maternal recognition of pregnancy in the pig (Bazer and Thatcher,
1977). Pope et al. (1982) demonstrated that the early secretion of E2 is involved
with the late equidistant spacing of the conceptus within the uterine horns.
Following the attainment of a 10 mm diameter, the conceptus begins its
rapid morphologic change in trophectodermal morphology, with the embryonic
disk remaining at -300llm during the rapid transformation of the trophoblast
(Mattson et aI., 1990). The conceptus now takes on an ovoid shape with the
trophectoderm cells remaining cuboidal in shape (Heuser and Streeter, 1929).
Conceptuses less than 9-10 mm do not appear to elongate at the same time as
their 10 mm Iittermates suggesting elongation is regulated somewhat by
individual conceptus development (Morgan et al., 1987).
Shortly after attaining an ovoid morphology, conceptuses transform
further into a tubular (13-40 mm in length) form (Heuser and Streeter, 1929;
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Anderson, 1978; Geisert et aL, 1982b). Tubular conceptuses have polygonal
shaped trophectoderm cells (Geisert et aI., 1982b; Mattson et aI., 1990). As
tubular conceptuses continue to undergo this morphological change into a thin,
filamentous form (100-150 mm in length), there is a rapid increase in conceptus
length with no increase in mitotic rate (Geisert et aI., 1982b; Pusateri at aI.,
1990). The conceptus rapidly elongates within 2-4 hours from initiation of the
tubular form. The elongated conceptus will become convoluted within the uterine
folds of the endometrium where the initial points of attachment begin to occur
across the endometrial surface (Danstzer, 1985; Keys and King, 1990).
Initiation of estrogen secretion and elongation is closely timed with the
emergence of mesodermal outgrowth (as reviewed in Geisert, et al. 1990).
Yelich et al. (1997b) indicated that the time of mesodermal outgrowth (4-5 mm
spherical conceptus) coincides with the first conceptus gene expression for
brachyury, a transcription factor needed for mesodermal differentiation.
Aromatase gene expression also increases in early 4-5 mm spherical embryos.
Presence of brachyury, thus mesodermal differentiation, may be involved in
regulating steroidogenic events in the conceptus.
Other factors may initiate estrogen production besides brachyury.
Presence of high concentrations of insulin-like growth factor-I (IGF-I) in the
uterine lumen during early conceptus development has been proposed to
enhance steroidogenesis as well as aid in the continued growth and expansion
of the conceptus (Simmen et al., 1989, Hofig et aI., 1991a; Ko et al., 1994;
5
Simmen et aI., 1995). Presence of IGF-I receptors on the trophectoderm surface
during peri-implantation (Corps et aI., 1990) would suggest that IGF-I has a
direct action as a mitogenic factor (Lewis et al. 1992) and possible inducer of
protein synthesis in vitro (Estrada et aI., 1991) by the -conceptus. However,
Chastant et al. (1994) was unable to detect IGF-I receptors through
immunocytochemical localization, although IGF-II receptors were very evident.
Lack of the IGF-I receptor would negate the IGF-I binding on the conceptus, as
IGF-II receptors lack high affinity for IGF-1. Nonetheless, Hofig et al. (1991 a)
demonstrated increased conversion of testosterone to estradiol when IGF-I is
supplemented in culture media. The question still remains whether IGF-I can act
directly on the conceptus (through a receptor) to increase conceptus estrogen
release, or indirectly through endometrial release of other growth factors, as
IGF-I receptors are present in the endometrium and myometrium (Hofig et al.,
1991b).
Factors that regulate the trophoblast remodeling are conceivably caused
by the cellular morphogen, retinoic acid (Harney et al. , 1990). One of the major
proteins in the uterus during the time of conceptus estrogen synthesis is retinol
binding protein (RBP) (Trout et aI., 1992; Harney et aI., 1994). Retinol binding
protein serves to deliver retinol from plasma across the uterine endometrium to
the lumen for the developing conceptus. The developing porcine conceptus also
produces RBP (Harney at aI., 1990). Harney and co-workers (1994) indicated
that RBP mRNA was detectable in the endometrium, the myometrium and
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conceptus. Low amounts of endometrial RBP mRNA on day 12-15 suggest that
uterine lumenal RBP detected after day 12 is of conceptus origin. Conceptus
RBP may serve to protect the conceptus from toxic levels of retinol, as well as
serving to distribute retinol to all available cells. In order for retinol to have its
biologic effects on the conceptus, such as production of extracellular matrix
proteins (De Luca, 1991) and cell adhesion molecules (Agura et aI., 1992), it
must act through its nuclear receptor. Yelich and co-workers (1997a)
demonstrated that retinoic acid receptor (RAR) mRNA is expressed in porcine
conceptuses. Gene expression for RAR-a, -13, and -y is detectable in day 10-12
conceptuses with RAR-a increasing linearly in 4-8 mm spherical conceptuses
(consistent with RBP expression) and remaining elevated until another sharp
increase occurs at the filamentous stage of development. Furthermore,
transforming growth factor-p (TGFP), a regulator of cellular growth and
differentiation and extracellular matrix protein modifiers, also increased in a
similar fashion to that of RARa gene expression (Yelich et aI., 1997a). The
presence of RBP, RAR, and TGFp provide an attractive model for initiation
and/or remodeling that occurs during conceptus elongation in the pig. Geisert
and Yelich (1998) proposed a model for trophoblastic elongation in the pig.
Conceptus estrogen, acting on its receptors in the endometrium provides the
initial release of uterine RBP. Retinol binding protein carries retinol to the
conceptus directly or may relay the retinol to conceptus RBP. Retinol that is not
bound activates its receptors located in the trophectoderm. Through activation of
RAR, TGFp gene expression (and other possible morphogens) is turned on,
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resulting in remodeling of the extracellular matrix allowing migration of
endodermal cells and restructuring of trophectoderm.
Embryonic Mortality in the Pig
In 1923, George Corner determined a good measure of ova shed at
ovulation was to count the number of CL present on the ovary. He went on to
note that as gestation proceeded, the number of conceptuses were almost
always less than the number of CL (Corner, 1923). Since the time of Corner,
significant effort has been concentrated on the time period and cause of
embryonic loss in the pig (Pope, 1994).
Fertilization rate in the pig is approximately 95%, and with the exception
of chromosomal aberrations, few embryos are lost prior to initiation of
steroidogenesis (Polge, 1982). Between days 12-18 of gestation, nearly 30% of
conceptuses are estimated to be lost (Pope, 1994). Initial conceptus loss has
been proposed to be due to littermate diversity (Le. differences in developmental
stages) (Pope et aI., 1982a). Embryonic loss is thought to stem from lack of
adequate uterine space for each conceptus, and therefore, uterine capacity
dictates number of conceptuses that will survive. Treatments to exceed uterine
capacity include superovulation, superinduction and unilateral-hysterectomy-
ovariectomy (UHO) (Christenson et aI., 1987). Superovulation increases the
number of ova shed while superinduction is the transfer of additional embryos
into the uterine lumen. In the UHO female, the remaining ovary compensates for
the lost ovary and ovulates the same number of oocytes to be fertilized that will
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be contained in half the uterine space. Approximately 30% of embryos are lost in
limited uterine capacity studies (Dzuik, 1968; Christenson et aI., 1987; Dzuik,
1987). Sometime after day 30, uterine capacity will begin to take effect, so
superovulated or superinduced litters will have the same number of fetuses as in
untreated controls (except UHO females, where they will have % fetuses
normally present) (Dzuik, 1968; Pope et aI., 1972; Fenton et aI., 1972; Huang et
aI., 1987).
Evidence exists suggesting that embryonic diversity is at the root of the
majority of embryonic loss, where the smaller, less developed conceptuses
perish in response to their larger, more developed littermates. Asynchronous
embryo transfer experiments were the first to implicate littermate diversity as a
cause of embryonic mortality in the pig (Pope et aI., 1982a).
Pope and co-workers (1982a) transferred day 5 or 7 embryos into day 6
recipients and allowed them to develop until day 11.5, 60 or 70. More older
embryos survived compared to the younger embryos on day 11.5 and
particularly at day 60 and 70. Further, in superinduction experiments, Pope at al.
(1986a) demonstrated that embryos transferred into a less advanced uterine
environment are more competitive for survival, versus the less competitive
position of embryos when placed into a more advanced uterine environment with
endogenous embryos. Wilde et al. (1988) reported that smaller embryos are not
less viable than their larger littermates and can survive if placed together in the
same uterus void of larger conceptuses.
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Further evidence that littermate diversity is the cause of early embryonic
mortality stems from experiments artificially accelerating uterine secretions.
Geisert et al. (1982c) demonstrated that uterine secretions could be advanced
approximately 24 hours in cyclic gilts to mimic pregnant uterine secretion, if they
were administered exogenous estrogen. Altering the uterine milieu with estrogen
sets up a hostile environment for developing conceptuses. Other experiments
have demonstrated that asynchronous administration of estradiol results in
embryonic loss by alterations in uterine secretions (Pope et aI., 1982b) as well
as loss of the uterine g,lycocalyx (Blair et aI., 1991).
Maternal Recognition of Pregnancy in the Gilt
Maternal recognition of pregnancy, first coined by Short in 1969, is defined as
the method derived from the conceptus to prolong the life span of the corpora
lutea (CL) and therefore maintain peripheral plasma concentrations of
progesterone. Normal luteal regression during the estrous cycle of the gilt.
occurs on day 15 through release of the luteolytic agent, prostaglandin F2Cl (PGF)
(Moeljono et a!., 1976). The signal for maternal recognition of pregnancy in the
pig is triggered by conceptus estrogen secretion on day 12 (Perry et aI., 1973).
Initial estrogen production on day 12 is reinforced be~een day 12-15 with a
second sustained epis,ode of conceptus estrogen release (Zavy et aI., 1980;
Geisert et aI., 1982a; Stone and Seamark, 1985). This two-phase secretion of
conceptus estrogen secretion sustains pregnancy until term. Bazer and Thatcher
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(1977) proposed the theory of maternal recognition of pregnancy in the gilt.
Under progesterone stimulation, in cyclic gilts on day 12-18, PGF is released
from the glandular and surface epithelium into the peripheral circulation via
uterine capillaries (endocrine direction) (Bazer and Thatcher, 1977). In the
presence of the porcine conceptus (or exogenous estrogens) the direction of
endometrial PGF release is shifted from the endocrine direction, to an exocrine
direction, into the uterine lumen. Lumenal PGF increases tremendously during
early pregnancy. Furthermore, the conceptus is also producing PGF and
prostaglandin E (PGE), of which PGE is a vasodilator. Although most PGF is
sequestered in the uterine lumen, there may be enough that escapes into the
bloodstream to cause luteolysis. In the presence of the conceptus secretion of
estrogen and PGE, there may be another system that protects the porcine CL
from luteolysis by PGF. Sulfated estrogens (estrone and estradiol) are also
released from the uterine lumen, that may reach the CL which has sulfatase
activity (see review Ford, 1985). Estrone and estradiol can be hydroxylated into
catechol estrogens that serve to further increase blood flow to the CL (Stice et
aI., 1987). In an in vivo study, Ford and Christenson (1991) demonstrated that
estrogen alone can not prevent luteolysis. Unlike intraluteal E2 admini,stration,
intraluteal administration of PGE protected individual CL against concomitant
PGF2a administration (Ford and Christenson, 1991). At PGE: PGF2a ratios of 4: 1,
CL weight and progesterone content was significantly greater than
administration of PGF2a alone (Ford and Christenson, 1991). Sequestering of
PGF in the uterine lumen, the ability of catechol estrogens to sustain blood flow
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to the Cl, and luteal protection of PGE maintains progesterone levels necessary
for pregnancy.
Endometrial Changes During the Estrous Cycle and Early Pregnancy
As early as 1921, Corner documented that the porcine uterine lumenal
and glandular epithelial morphology changed throughout the estrous cycle and
early pregnancy. As the estrogen to progesterone ratio changed due to ovarian
hormones, uterine growth occurs (Davis and Blair, 1993). With the initiation of
conceptus estrogen on approximately day 11 of pregnancy, the uterine
epithelium becomes markedly different from its non-pregnant counterpart
(Corner, 1921; Geisert et aI., 1982b; Keys and King, 1990). Prior to the time of
conceptus elongation, the uterus prepares itself by producing components (i.e.
growth factors, ions, and hormones) whose release is advanced under
conceptus control in early pregnant versus cyclic gilts. In order to better
understand uterine changes associated with the time of conceptus elongation
and estradiol production, many investigators have compared cyclic versus early
pregnant uterine flushings, endometrial explant cultured media, and endometrial
monolayer cell cultures from gilts to study some of the components that may be
playing a role in the orchestration of the conceptus with the uterine environment
(Squire et aI., 1972; Knight et aI., 1973; Knight et aI., 1974a, 1974b; Bazer,
1975; Moffatt et aI., 1980; Murray et aI., 1980; Basha et aI., 1980a, 1980b;
Geisert et aI., 1982a; Fazleabas et aI., 1984; Young et aI., 1987; Roberts and
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Bazer, 1988; Stroband and van der Lende, 1990; Roberts et aI., 1993; Murphy
and Ballejo, 1994; Geisert and Yelich, 1998)
To better understand and characterize uterine differences between cyclic
and early pregnant gilts caused by the conceptus, Geisert et al. (1982a)
conducted a series of experiments. First, uterine flushing concentrations of
estrone (E l ), E2 , E1 sulfate (E1S), E2S, PGE, PGF, total protein and calcium were
measured in cyclic and pregnant gilts. Unlike the unchanging estrogens found in
cyclic females, the uterine lumen of pregnant gilts contained high concentrations
of E2, E1S and E2S that was correlated with increasing conceptus size on days
11-12. Uterine estrogen content decreased after day 13 following the completion
of trophoblastic elongation. Calcium remained unchanged in nonpregnant
flushings, but there was a marked increase on day 11 consistent with the initial
peak increase in conceptus estrogen secretion. Geisert and coworkers (1982b)
also reported a 2-4 fold increase in total protein in day 12-14 pregnant gilts and
Murray et al. (1972) reported a peak of uterine protein content on day 15, which
declined to low concentrations by day 18 of the estrous cycle. The release and
increase in total protein from the uteri of cyclic gilts was delayed approximately
one day, in comparison with pregnant uterine flushings (Geisert et aI., 1982b).
Prostaglandin E and PGF concentrations remain between 1-4 ng between days
10.5 to 14 in cyclic gilts. However, although identical ~o non-pregnant flushings
on day 10.5, PGE and PGF levels increase 6-8 fold on day 11, further increasing
on day 12 until becoming 100 fold greater by day 14 (Geisert et aI., 1982b).
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Further st.udies to clarify conceptus influence on the uterine milieu were
conducted by Geisert et al. (1982c). By a,dministering estradiol valerate (EV) to
cyclic gilts, direct effects of estrogens on the uterine secretory activity could be
studied. Administration of EV to gilts on day 11 produced similar concentrations
of free estrogen within the uterine lumen that were found in pregnant gilts
(Geisert et aI., 1982a). A transient 24 hour increase in lumenal uterine content of
calcium was detected 12 hours after the injection of EV, as was seen in pregnant
gilts with elongating conceptuses on day 12.
These experiments clearly illustrate that the estrogen that is conceptus
derived is responsible for the change in the porcine uterine environment (Geisert
et aI., 1982a,b,c). Other investigators (Ford et aI., 1982a, Pusateri et aI., 1990)
have also demonstrated similar findings, which corresponded with conceptus
growth and changes in uterine environment. Increases in estradiol in the pig is
necessary for maintenance of pregnancy due to its luteostatic effect through
sequestering PGF within the uterine lumen on day 15 (Bazer and Thatcher,
1977). Estradiol is also responsible for increasing blood flow to the pregnant
uterus needed for delivery of nutrients and oxygen to the developing
conceptuses (Ford and Christenson, 1979; Ford et aI., 1982b).
Conceptus-Endometrial Interactions
Initially, the early, unattached conceptus can obtain all of its nutrients
from the uterine milk, or histotrophe. Histotrophe is composed of a large quantity
of the purple acid phosphatase, uteroferrin, as well as serpins and lysozyme
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(see Roberts et ai, 1993). Uteroferrin serves to transport iron while uterine
serpins are known to be serine protease inhibitors. Uterine lysozyme, identical to
porcine spleen and stomach lysozyme, is bacteriostatic (see Roberts et aI.,
1993). However, once the conceptus attains the length of a meter in leng.th by
day 15 of gestation, the necessity for increased nutrients can not be provided
from histotrophe alone. Unlike other species that actively invade into the
endometrium (e.g. the human and rat), porcine conceptuses attach to the
endometrium to set up an epithelial-chorial placenta (Keys and King, 1990).
Interestingly, if the porcine conceptus is placed outside ·the uterine lumen, it will
invade into the surrounding tissue to form a syncytium (Samuel, 1971; Samuel
and Perry, 1972) suggesting the porcine conceptus is highly proteolytic.
Therefore, porcine endometrium must contain inhibitors to the proteolytic factors
from the conceptus. Trophoblastic attachment to the uterine surface epithelial
glycocalyx present on the microvilli provides close contact between the maternal
endometrial surface and the conceptus to establish the placenta attachment and
development for nutrient transport (Keys and King, 1990). However, before the
conceptus can attach, the uterine surface epithelium must be altered for contact
with the conceptus. Therefore, the opening of the "implantation window" is under
ovarian hormone regulation.
Peri-Implantation Window
Prior to the period of implantation in the pig, the apica,1 border of surface
epithelium contains microvilli that have a thick glycocalyx that becomes
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diminished during the time of trophoblastic attachment (Dantzer, 1985; Keys and
King, 1990) or exogenous estrogen treatment in the pig (Blair et aI., 1991). The
glycocalyx present on the epithelial microvilli is essential for the conceptus to
adhere, and if absent, does not appear to allow attachment to occur and
conceptuses degenerate (Blair et aI., 1991). Even though the glycocalyx is
essential for conceptus survival, some glycoproteins that are part of this matrix
may serve as steric hindrance to adherence molecules during the period prior to
opening the "implantation window". Mucin-1 (Muc-1) is a large (200-1000 kD)
integral transmembrane glycoprotein that is associated with the porcine
glycocalyx (Bowen et aI., 1996, 1997). Bowen et al. (1996) detected expression
of Muc-1 during the estrous cycle and early pregnancy, which is consistent with
the theory that Muc-1 is an anti-adhesive molecule first indicated in the rat
(Surveyor et aI., 1995). Muc-1 is present on the apical surface of uterine
epithelial cells in ovariectomized gilts receiving estradiol, but absent in gilts
treated with progesterone or progesterone and estradiol for ten days, indicative
of the time of first progesterone receptor down-regulation in the uterine
epithelium (Geisert et aI., 1994). Muc-1 is down regulated during the time that
the conceptus initiates attachment to the uterine epithelium. This is consistent
with mouse data demonstrating that Muc-1 disappears during the time of
implantation in the rodent (Braga and Gendler, 1993; Surveyor et al. I 1995).
Disappearance of Muc-1 may reduce steric hindrance to other molecules of the
glycocalyx and allow for the conceptus interaction with the epithelium for
trophoblastic attachment.
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The extracellular matrix of the conceptus, as in all cells, has more of a
role than just support. Some of the extracellular matrix proteins that are known to
be in the expressed in the conceptus are fibronectin, laminin, vitronectin, and
collagen type IV (see review Murphy and Ballejo, 1994). For cell to cell contact
between the conceptus and uterine epithelium, there must be some type of
receptor on the epithelial cell surface of the uterus. Integrins are cell surface
glycoproteins that serve to act as receptors to extracellular cellular matrix
proteins (see Hynes, 1992). All integrins are composed of an ct and f3 subunit,
whose various combinations dictate cell function (Hynes, 1992). There are
currently eight known f3 subunits and fourteen known ct subunits (see Hynes,
1992). Bowen and coworkers (1996, 1997) investigated the endometrial and
conceptus expression of a" 0.3, Cl.4, as, ctv, f3t, and Jh throughout the estrous cycle
and early pregnancy of the pig. Evidence that both f3 and a subunits occurred in
the same cell type suggests possibilities of heterodimers. Subunits that
appeared in both the trophectoderm and the uterine epithelium were Cl.4, as, ctv,
f3,. and Jh with peak.expression of Cl.4, (ls, a v, and f3, appearing on days 11-15 of
pregnancy. Furthermore, 0.3, o.y, and f33 subunits were not altered by steroid'
treatment on ovariectomized gilts, with levels of o.y and f33 remaining high at all
days. However, where estrogen treatment down-regulated <X.4 and 0.5,
progesterone treatment up regulated a, and f3,. Heterodimers Cl.4f3" asP, and a.."f3,
are known to bind to fibronectin (Hynes, 1992). Fibronectin was only detected on
the porcine conceptus trophectoderm (Bowen et aI., 1996). Richoux et al. (1989)
reported fibronectin to be present on day 5 porcine blastocysts with laminin first
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appearing in day 10 conceptuses. Tuo and Bazer (1996) reported onoofetal
fibronectin on conceptuses on days 12 and 15. Vitronectin is also present in the
trophectoderm, uterine epithelium, and interestingly at the site of implantation
(Bowen et aI., 1996). Vitronectin has been shown to bind to the heterodimers of
avf31 and a vf33 (Hynes, 1992). The expression of the integrins present on the
uterine epithelium, as well as their ligands on the trophectoderm, which are
highly expressed at the time of implantation, suggests a potential role for integrin
involvement in the attachment process in pigs.
As mentioned earlier, the glycocalyx is made up of a plethora of
glycoproteins. In 1995, Geisert and coworkers reported the presence of a basic
30 kD glycoprotein (pGP30) fragment in the porcine lumen. Through
immunocytochemical analysis, pGP30 was detected within and on the surface
epithelium of the uterus with maximal expression on day 12 of the estrous cycle
and days 12-18 of pregnancy. Conceptus uptake of pGP30 was also apparent;
suggesting that pGP30 may be utilized by the conceptus. Geisert et al. (1995)
demonstrated that pGP30 was steroid regulated as progesterone increased
pGP30 in ovariectomized gilts.
Endometrial explant cultures secreted pGP30 but there was a detectable
alteration in size from day 10 to day 12 of the estrous cycle, with further
alteration in band number in day 12 pregnant tissue. Geisert et al. (1995)
suggested that conceptus estrogen and/or other conceptus derived components
are responsible for this reduction in Mr. Porcine GP30 was later found to be
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homologous to a member of the inter-a.-trypsin-inhibitor (10.1) family (Geisert et
aI., 1996).
As stated previously, when placed in an ectopic site outside the uterine
lumen, the porcine conceptus invades into the surrounding tissues forming a
syncytium (Samuel, 1971; Samuel and Perry, 1972). The endometrium has
incorporated into its secretions a series of protease inhibitors (see review
Roberts et aL, 1993). Fazleabas et al. (1983) first reported the trophectoderm
secreted plasminogen activator at the time of trophoblast elongation which
releases plasmin from plasminogen. Plasmin has been shown to be responsible
for cell migration, cellular remodeling and extracellular matrix regulation (Bode
and Dziadek, 1979; Fazleabas et aI., 1983; Werb et aI., 1990). Fazleabas et al.
(1983) and Stall ings-Mann et al. (1994) reported the presence of a protease
inhibitor specific for plasmin, chymotrypsin and trypsin in the uterus, which
keeps this proteolytic system in-check. Furthermore, an antileukoproteinase,
possibly regulated by TGFa., is present in the porcine uterine secretions (Farmer
et aL, 1990; Reed et aI., 1998). Antileukoproteinases are potential inhibitors of
neutrophil elastase and cathepsin G (Thompson and Ohlsson, 1986) and are
unique to epithelial-chorial placental species (Badinga et aI., 1994).
The serine protease inhibitor, bikunin, was also detected in porcine
endometrium (Diederich et aI., 1997). Via RT-peR, message for bikunin was
detected in cyclic and pregnant endometrium on days 10 and 12. However, gene
expression was significantly greater on days 15 and 18 of pregnancy. Individual
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conceptuses from day 10 and 12 also had detectable amounts of bikunin
(Diederich et aI., 1997).
Bikunin is also a member of the 10.1 family. The 10.1 family consists of 5
members; 4 heavy chains and one light chain (see review Salier et aI., 1996).
The light chain, bikunin, can be found alone or bound to heavy chain 1, heavy
chain 2, heavy chain 3, or heavy chains 1 and 2, or heavy chains 2 and 3 by
linkage of the glycosaminoglycan, chrondrotin sulfate (see review Salier et aI.,
1996). Inter-a-trypsin inhibitor heavy chain 1 has also been reported to be
expressed and localized in the porcine endometrium (Geisert, unpublished
data).
Inter-a-trypsin-inhibitors are major members of Kunitz-type protease
inhibitors (review in Salier et aI., 1996). A Kunitz-type inhibitor is one that has a
low molecular mass, a basic isoelectric point, and has at least one domain that is
inhibitory to serine proteases, such as trypsin, cathepsin G, and plasmin.
Although bikunin has 2 Kunitz-type domains, plasmin inhibitors more effectively
inhibit the above-mentioned proteases, thus the role of 10.1 as a protease
inhibitor is still being investigated (Salier et aI., 1996).
Inter-a-trypsin-inhibitor family members play an important role in
extracellular matrix (ECM) stabilization (see Bost et aI., 1998). The ECM is a
complex network of several macromolecules that allow for tissue cohesiveness.
The ECM also allows for cell migration and interaction between different cell
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types. A major component of ECM is hyaluronic acid (HA). The presence of HA
is often associated with HA-binding proteins (HASP) (see 80st et aI., 1998). The
linkage of lal proteins with HA was first discovered in the ovary and inflamed
synovial fluids (see 80st et aI., 1998). Inter-a-trypsin-inhibitors have now been
viewed as a major player in stabilization of ECM, as well as having a role in
protease inhibition.
Not only does lal playa role in ECM stabilization, lal also is involved with
inflammatory processes. lal gene expression is regulated by interleukin-6, an
important inflammatory mediator (Daveau et aI., 1993; Sarafan et aI., 1995.)
Inter-a-trypsin-inhibitor heavy chains (H) -1, -2, -3, and -4 all are derived from
separate genes with heavy chain mRNA 1-3 being known for some time, but it
wasn't until recently that lalH4 was known (Nishimura et aI., 1995). 8ikunin
shares its gene with a 1-microglobulin, which separates as it becomes a matured
polypeptide (Diarra-Mehrpour et aI., 1989).
Not all heavy chains can bind bikunin. Inter-a-trypsin inhibitor H4 does
not contain the consensus sequence needed to covalently bind bikunin. It was
therefore first termed as lal related protein, in the human (Saguchi et aI., 1995;
Nishimura et aI., 1995) and major acute phase serum protein in the pig
(Gonalez-Ramon, 1995). It wasn't until recently that these two proteins were
determined to be homologous, (Hashimoto et aI., 1996) and since gene structure
was similar, was classified as lal H4.
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Although the Kunitz-type domains are the only functional regions of the
protein that possess protease inhibitory activity, recent progress has determined
putative functional domains in the heavy chains. First, the von Willibrand-type A
domain has been located on lalH1, -H2, -H3, and -H4, which binds to integrins,
collagen, proteoglycans and heparin (Colombatti and Bonaldo, 1991). Secondly,
heavy chains 1 and 3 also contain a multicopper oxidase domain (Chan et aI.,
1995) whose ability to bind copper seems to have disappeared through
evolution, and therefore does not appear to be biologically active. Thirdly,
human lalH4's C-terminal sequence is rich in a proline, bradykinin-like domain.
The proline-rich region is surrounded by arginine residues and therefore make
this region sensitive to kallikrein cleavage (Nishimura et aI., 1995; Gonzalez-
Ramon, et al. 1995).
Recently, the N-terminal sequence of pGP30 detected in the porcine
endometrium (Geisert et aI., 1995), was determined to be homologous to lalH4
(Geisert et aI., 1998). Gene expression of porcine uterine lalH4-like glycoprotein
was specific to the endometrium and absent in conceptuses (Geisert et al.,
1998). Subjecting endometrial lalH4 to kallikrein has not been done to determine
if a 30 kD fragment (pGP30) is released. However, Hashimoto and co-workers
(1995) detected 55 and 25 kD polypeptides after incubating porcine plasma
lalH4 with kallikrein. Evidence that both pGP30 and IalH4 are present in the
porcine uterine lumen suggests kallikrein cleavage does occur in porcine
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endometrium. Besides the role that kallikrein may play in cleaving lalH4,
kallikrein is more noted for its regulation of kinin release.
Kininogen-Kallikrein-Kinin System
The mammalian blood contains three major protease cascades that are
activated by the Hageman Factor. These cascades include the blood
coagulation, fibrolysin and the kallikrein-kininogen-kinin (K-K-K) system. The
focus of this section will concentrate on the K-K-K system. The K-K-K system is
composed of several members that include the kininogens, kallikreins, kinins,
kallikrein binding proteins, and kininases (see review Bhoola et aI., 1992).
Briefly, high and low molecular weight kininogen are cleaved by plasma or tissue
(glandular) kallikrein, respectively, to liberate kinins, namely bradykinin.
Bradykinin is the active molecule in the system that functions to release
histamines, acts as a vasodilator, potentates prostaglandin release as well as
other vasoactive ~vents. Kinins are quickly inactivated by k,ininases that are
present within the tissues (See figure 2.1).
There are two pathways that make up the K-K-K system (see reviews
Shoola et aI., 1992; Carbini et aI., 1993; Rusiniak and Back, 1995; Margolius,
1996). The first is found in the peripheral vascular system. In the blood, when
trauma is caused or activated by coming in contact with collagen (intrinsic
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pathway), Hageman Factor is activated. Hageman Factor converts pre-kallikrein
into kallikrein that has a positive feedback on activating more Hageman factor.
Activated kallikrein acts on its normal substrate, high molecular weight
kininogen, to liberate bradykinin (see reviews Bhoola et aI., 1992; Carbini et aI.,
1993; Rusiniak and Back, 1995; Margolius, 1996).
An alternative pathway for the K-K-K system occurs in the tissue. Here,
plasma kallikrein, or other proteases in the tissue activate pro-kallikrein into
kallikrein. Glandular kallikrein acts on its normal substrate, low molecular weight
kininogen to release Iysyl-bradykinin, or kallidin, that is further converted to
bradykinin by amino-peptidase. Bradykinin is rapidly broken down to an inactive
form by kininases (see reviews Bhoola et aI., 1992; Carbini et aI., 1993; Rusiniak
and Back, 1995; Margolius,1996).
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Figure 2.1. Plasma and tissue (glandular) kallikrein proteolytic
pathways involved in bradykinin production and
degradation. Hatched arrows and + indicate positive
feedback loops.
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Kininogens
As mentioned previously, kininogens are gliycoproteins that serve as
substrates for the serine proteases, kallikreins. Plasma kallikrein cleaves HMW
kininogen to release the nonapeptide, bradykinin. Tissue, or glandular, kallikrein
cleaves LMW kininogen to release Iysyl-bradykinin, or kallidin (see reviews
Shoola et aI., 1992; Carbini et aI., 1993; Rusiniak and Sack, 1995; Margolius,
1996).
Splicing of a single human kininogen gene gives rise to high molecular
weight (HMW; 88-120 kD) and low molecular weight (LMW; 50-68kD) kininogen
(Margolius, 19 (Margolius, 1996). The first nine exons are the same for both HMW
and LMW kininogens, giving rise to the same amino acid sequence. The
difference between HMW and LMW kininogen lies beyond the bradykinin
sequence (exon 9), where HMW contains part of exon 10, and LMW, although
lacking exon 10, is unique for containing exon 11. There is another type of low
molecular weight kininogen found only in the rat, named T-kininogen (see
reviews Shoola et aI., 1992; Carbini et aI., 1993; Rusiniak and Back, 1995;
Margolius, 1996; Schmaier, 1997), which will not be discussed.
Kininogens are composed of a heavy chain and a light chain, of which the
heavy chain (composed of domains 1-3 and the bradykinin moiety) is identical ,in
both HMW and LMW kininogen (Schmaier, 1997). The light chain is unique to
each kininogen, and gives each its own unique physiologic function. Comprising
the shared heavy chain, domains 1, 2 and 3 are known to bind calcium (Ishiguro
et al. I 1987), inhibit calpain, papain and cathepsin L, respectively with domains 2
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and 3 shartng inhibition of papain and cathepsin l (see Colman, 1996; Schmaier,
1997). Domains 2 and 3 also appear to playa role in cysteine protease inhibition
as they contain three disulfide loops and a highly conserved QWAG sequence
(Coleman, 1996). Domain 4 is the bradykinin region, and serves as the cleavage
site for kallikrein.
The li.ght chain of HMW kininogen includes a histidine rich domain 5 and
C-terminal domain 6 (see Schmaier, 1997). The histidine rich domain is essential
in HMW kininogen's role in the coagulation cascade involved with the intrinsic
pathway. Domain 6 has sites that bind pre-kallikrein as well as the Hageman
Factor, which are essential for initiation of the cascade (see Coleman, 1996;
Schmaier, 1997). LMW kininogen has a very small light chain, comprised of only
a portion of domain 5, which lacks the histidine-rich segment (see Schamier,
1997; Coleman, 1996).
It was once thought that the I,iver was the only source of kininogen.
However, LMW kininogen has also been demonstrated to be present in the
adrenal (Wang et a/., 1996), human placenta (Hermann et aI., 1996) and rat
uterus (Brann et a/., 1995) while HMW kininogen is expressed in endothelial cells
(see review Reddigari et aI., 1995). Since kininogens can be synthes'ized by and
have actions on various cell types, Takano and coworkers (1995) used mouse
fibroblasts to study LMW kininogen in response to dibutyryl cAMP (dbcAMP),
forskolin, PGE and tumor necrosis factor ex (TNFex). Kininogen release was
stimulated by dbcAMP; and forskolin, an activator of adenylate cyclase,
indicating that kininogen secretion occurs through a cAMP second messenger
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system. In order to further test this hypothesis, kininogen secretion was tested in
the presence of PGE, which stimulates cAMP production in, fibroblasts. After 24
hours, levels of kininogen were significantly increased in the presence of PGE.
Since TNFa and IL-1 induced PGE production in fibroblasts, they were also
examined. Fibroblasts receiving TNFa stimulus, but not IL-1 or IL-6, increased
kininogen secretion (Takano et aI., 1995). Kininogen not only acts to serve as
kallikrein's substrate for kinin production, but also serves as a cysteine protease
inhibitor. Evidence that fibroblasts can mediate kininogen secretion in response
to inflammatory agents such as TNFa and PGE, suggest that the connective
tissue may be playing a role at the site of inflammation.
Kallikreins
Kallikreins are serine proteases that liberate kinins from kininogen (see
reviews Shoola et aI., 1992; Carbini et aI., 1993; Rusiniak and Sack, 1995;
Margolius, 1996). Investigators have found two types of kallikrein, plasma
kallikrein and tissue, or glandular kallikrein. Each can be characterized by
differences in sUbstr?Jte types, tissue localization, function and molecular
structure. Plasma kallikrein cleaves HMW kininogen and is located in the
peripheral blood where it is involved in the intrinsic pathway, whereas tissue
kallikrein acts on LMW kininogen, and functions to release kinins from many
tissues (see review Shoola et al., 1992).
As reported by Chao et al. (1996), Abelous and Bardier in 1909, first
identified tissue kallikrein activity in a human patient's urine who experienced a
dramatic lowering of blood pressure. Similar hypotensive activity was
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demonstrated in dogs and rabbits by independent researchers (see Shoola et aI.,
1992). As Shoola et al. (1992) indicate, Wehl:e and co-workers studied an active
factor present in blood, pancreas and salivary glands, which they named
kallikrein, from the Greek word, kallikreas meaning pancreas.
The gene families of plasma and tissue kallikrein differ, as plasma
kallikrein is derived from a single gene in the liver and glandular kallikrein is a
multiple gene family of which 3 genes have been described in the human, 20 in
the rat and 24 in the mouse (see reviews Bhoola et aI., 1992; Carbini et al. , 1993;
Rusiniak and Back, 1995; Margolius, 1996). Regardless of species and specific
tissue, all tissue kallikreins consist of five exons and 4 introns (see Margolius,
1996). Members of the kallikrein gene family are a subfamily of serine proteases
that are specific for cleaving arginine residues (see Bhoola et al., 1992). True
tissue kallikrein (rGK-1) and tonin (rGK-2) are present in the rat, human and
mouse (see Margolius, 1996). Tonin is a member of the kallikrein family, with
specific function to cleave angiotensinogen to release angiotensin II (Boucher et
aI., 1994). True kallikrein genes are designated as rGK-1 in the rat, hRKALL in
the human, and mGK-6 in the mouse (see Bhoola et aI., 1992). Tissue kaHikreins
are acidic glycoproteins of 24-45 kD which is consistent across many species
and tissue types (figure 2).
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Species
Pig
Rat
Human
Tissuel Organ
Pancreas
Salivary Gland
Anterior Pituitary
Pancreas
Salivary Gland
Intestinal Tissues
Anterior Pituitary
Kidney
Uterus
Kidney
Pituitary
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Endometrium
Adrenal Gland
Reference
Fiedler et aI., 1981
Lemon et aI., 1979
Powers and Nasjletti, 1984
Hojima et aI., 1975
See Richards et aI., 1996
See Shoola at aI., 1992
Jones et aI., 1990
Bascands at aI., 1995
Brann et al., 1995
Valdes et aI., 1996
Chen et aI., 1995
Clements et aI., 1996
Herrala et aI., 1997
Clements and Mukhtar, 1994
Wang et al., 1996
Figure 2. Tissue kallikrein in various tissue types and species.
Besides serving to cleave its natural substrate, kininogen, kamkreins have
also been noted to act on other molecules. Plasma kallikrein converts pro-renin
to renin, which is the initiator of the renin-angiotensin system (Sealey et aI.,
1978). Plasma kallikrein can also convert plasminogen to plasmin (Mandie and
Kaplan, 1977). Studies conducted with the rat pituitary indicate that tissue
kallikrein cleaves prolactin to its active form, in vitro, suggesting a possible role in
the biosynthesis of prolactin (Powers, 1993). Powers (1987) demonstrated that
expression of rGK-1 in the pituitary gland is regulated by estrogen. Furthermore,
tissue kallikrein is induced by estrogen and inhibited by dopamine in females
attaining puberty, with no change noted in male rats (Hatala and Powers, 1988).
Rat pituitary kallikrein did not change during the estrous cycle or early
pregnancy, but on day 15 of gestation there was a sharp increase, declining to
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normal levels 5 days post-partum. Jones et al. (1991) indicated that only
lactotrophs are associated with tissue kallikrein in the anterior pituitary.
Other proteins may be cleaved by kallikrein are the binding proteins of
insulin-like growth factors. Insulin-like growth factors (IGF) are important for
cellular growth and various other processes. Regulators of IGF are its binding
proteins, IGF-BPs. IGF-BP are known to have prot.eases that serve to release
IGF, thereby allowing IGF to have its cellular action. Currently there are three
classes of IGF-BP proteases: kallikreins, cathepsins, and matrix
metallinoproteases. Cohen and co-workers (1992) demonstrated that seminal
plasma kallikrein, prostate-specific antigen (PSA), is an IGF-BP protease that
cleaves IGF-BP3. PSA is a member of the kallikrein gene family in the human
(see review Shoola et aI., 1992). Furthermore, another member of the kallikrein
gene family has been shown to modulate the IGF system. In 1996, Rajah and co-
workers noted that 7S nerve growth factor (NGF) displayed protease activity
against IGF-BP4 and -BP6. These authors suggest that the synergistic
relationship between IGF and NGF may help mediate growth promoting activities
including cell development and repair (Rajah et aI., 1996).
The K-K-K system has also been detected in reproductive processes in
both male and females. Schill and Haberland (1974) reported that when porcine
pancreatic kallikrein was added to human sperm, motility was increased.
Kallikrein is present in prostate (in humans only) and sertoli cells of the testis
(Schill and Haberland, 1974). Presence of kallikrein in Sertoli cells suggests a
role in spermatogenesis (see Shoola et al., 1992). Kinins acting to increase
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-glucose uptake may be one of the reasons for an increase in sperm motility (see
Bhoola et aI., 1992).
A number of reproductive processes have similarity to inflammatory
reactions. The K-K-K system is present and active during ovulation (Gao et aI.,
1992), implantation (Valdes et al.. 1996; Corthorn et aI., 1997), menses
(Clements and Mukhtar, 1994) and parturition (Brann et aI., 1995). Gao and c0-
workers (1992) studied parallelism between the inflammatory response and
ovulation in the rat. Kallikrein levels and estrogen concentration were highest at
time 0 (injection of hCG) and then dramatically decreased with a slight elevation
at 20 hours (ovulation). Total kininogen levels increased at 10 hours, dropped at
20 hours and peaked at 30 hours post-injection. Ovarian cathepsin B activity
was lowest at 10 hours post-injection, corresponding to the high levels of
kininogen. Changes in kininogen and kallikrein during the ovulatory process
suggest the K-K-K system is present and active at ovulation.
Kallikrein activity has also been detected in the rat uterus as well. Valdes
et al. (1996) previously reported finding kallikrein activity in rat uteri and kallikrein
gene expression present in endometrium from cyclic and early pregnant rats.
During the estrous cycle, immunoreactivity to a polyclonal rat kallikrein antibody,
was localized in the apical surface of glandular and lumenal epithelium, with
greater intensity occurring during proestrus. During pregnancy, kallikrein staining
intensified by day 5 with staining increasing slightly and in some cases,
protruding into the lumen on day 6. These results may possibly indicate a release
of kallikrein into the uterine lumen. Epithelial cells in the implantation chamber
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stained on day 7. Following completion of placentation, on day 9-10 kallikrein
staining was absent. On day 12, staining for kallikrein was evident in granules
contained within decidual cells, intensifying by day 14. Days 16-21, staining was
detected on the maternal blood vessels, just under the placenta throughout the
remainder of gestation. No staining was detected in the stromal fibroblasts,
myometrium or basal placenta. The authors suggest that presence of kallikrein
within cells of the implantation chamber maybe mediating the decidualization
process. On days 6-7, there is an increase of permeability, possibly due to kinin
release.
Detection of kallikrein throughout the estrous cycle and pregnancy in the
rat suggests that it may be mediated by steroid hormones. To get a better
understanding of how hormones could be influencing kallikrein release, eorlhorn
et al. (1997) evaluated hormonal and intralumenal stimulation on kallikrein
release. Uterine weight increased as weU as kallikrein activity with increased
amounts of estradiol administered to ovariectomized rats. Progesterone
supplemented ovariectomized rats had no significant increase in uterine weight,
and there was a decrease in kallikrein activity. In pseudopregnant rats, as uterine
weight and protein content decreased, kallikrein content rose from day 1 to day
5, reaching a plateau on day 7. Induction of decidualization with intralumenal oil
injection resulted in a 3-4 fold greater increase of kallikrein within the
decidualized horn compared to the untreated contralateral horn. Furthermore, in
unilateral pregnant rats, the decidualized hom had 2 to 3 fold more kallikrein than
its non-pregnant counterpart. These studies provide clear indication that estrogen
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stimulates kanikrein release whereas kallikrein secretion is impeded in presence
of progesterone.
Kallikrein Inhibitors
Although the roles of kininogens, kallikreins, kinins and kininases have
been studied extensively, there is limited literature on kallikrein inhibitors. In the
early 1980s, oJ-antitrypsin, a serine protease inhibitor, was reported (Geiger et
al. 1981). Geiger et al. (1981) indicated that a 1-antitrypsin did inhibit kallikrein
activity, however, the coupling of the two proteins leading to inhibition, is a very
slow process. Chao and coworkers (1996) reported a new kallikrein binding
protein, which they characterized and cloned. These authors named the kallikrein
binding protein, kallistatin. Kallistatin binds more strongly to kallikrein than other
proteases. Chen et al. (1995) indicated that kaUikrein and kallistatin mRNA are
localized in the same cells in the human kidney, suggesting a potential role in
kallistatin regulating kallikrein activity.
Kinins
Kinins are ,,:asoactive peptides produced from kallikrein activity. Kallidin
and bradykinin are the mammalian sources that will be discussed. Plasma
kallikrein releases the nonapeptide, bradykinin, from HMW kininogen. Kallidin
comes from tissue kallikrein action and is 10 amino acids long (Iysl-bradykinin)
that is converted to bradykinin by aminopeptidases (see reviews Shoola et aI.,
1992; Rusiniak and Back, 1995; Carbini et aI., 1993; Margolius, 1996). There are
two other kinin sources in mammals that are only detected in the rat at this time.
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These are T-kinin (lle-Ser-bradykinin), and Met-T-kinin (Met-lle-Ser-bradykinin)
that have been limited to plasma (see Bhoola et aI., 1992). Kinins are rapidly
degraded in the body by kininases (see reviews Bhoola et ai, 1992; Rusiniak and
Back, 1995; Carbini et ai, 1993; Margolius, 1996). Kininases remove the terminal
arginine by carboxypeptidase. This carboxypeptidase, kininase II, also is
responsible for converting the inactive angiotensin I to the potent angiotensin II
(Rusiniak and Back, 1,995). Estimated half life of bradykinin and kallidin in blood
is < 30 seconds (McCarthy et aI., 1965).
Kinins have been known to be involved in a variety of biological functions
that include increasing vascular permeability, contract smooth muscle of the
lungs, intestine and uterus, increasing in glucose uptake and increase sperm
motility (see Bhoola et aI., 1992). At the cellular level, kinins have been known to
stimulate by release of neurotransmitters (norepinephrine), histamine, activating
platelet-activator factor, leukotrienes, and prostaglandins (see review Bhoola et
aI., 1992). Bradykinin appears to stimulate prostaglandin synthesis by a
calcium/calmodulin mechanism (Cooper et aI., 1'985). Kinins can also stimulate
release of renin from the kidney and catecholamines from the adrenal medulla.
Kinins carry out their actions by attaching to their receptors that are bound to a
G-protein-coupled second messenger system (see Bhoola et aI., 1992).
Statement of the Problem
The process of porcine conceptus elongation and attachment to the
uterine epithelium remains an enigma. Many components contribute to the milieu
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-of the porcine uterus and must be synchronized with the conceptus for
successful early embryonic development and placental establishment. Uterine
protein profiles are dictated by estrogen; the conceptus derived signal for the
maternal recognition of pregnancy in the pig (Bazer and Thatcher, 1977).
Identification of 1a.IH4 in the porcine uterus, with its unique characteristic of
kallikrein cleavage, and detection of pGP30 in the porcine uterine lumen, suggest
that kallikrein may be synthesized by the porcine endometrium (Geisert et aI.,
1995). Regulation of ia.IH4 may be necessary for conceptus attachment and
establishment of placentation. Furthermore, presence of uterine kallikrein
suggests a functional kininogen-kallikrein-kinin system in the porcine uterus.
Events that occur in other tissues via kallikrein (i.e. prostaglandin production,
histamine release, increase in vascular permeabil.ity, increase in blood flow) all
occur during the critical time of conceptus elongation and attachment in the pig.
Presence of kallikrein in the porcine uterine lumen needs to be evaluated.
If kallikrein is detected, changes in enzymatic activity, tissue source, and gene
expression throughout the estrous cycle an early pregnancy should be
investigated.
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-CHAPTER III
Detection of Kallikrein gene expression and enzymatic activity in porcine uterus
during the estrous cycle and early pregnancy
Introduction
During early pregnancy, porcine conceptuses undergo a rapid
morphological transformation from a 10 mm sphere to a long filamentous thread
within the course of a few hours on Day 12 of gestation (Geisert et aI., 1982b).
This process allows the release of conceptus estrogen to act as the signal for
maternal recognition of pregnancy across the endometrium in the pig (see
Geisert et aI., 1990). Conceptus synthesis and release of estrogen alters uterine
secretion of proteins (Roberts et aI., 1993), prostaglandins (Bazer and Thatcher,
1977), uterine blood-flow (Ford et aI., 1982), and uterine cellular morphology
(Geisert et aI., 1982b; Keys and King, 1990). Although a great amount of
information is available for conceptus estrogen influence on uterine activity,
factor(s) induced by conceptus estrogen to orchestrate uterine changes
conducive to conceptus development and survival are not fully understood.
Implantation by pig conceptuses is typically non-invasive forming the
diffuse, epitheliochorial placenta of this species (see Keys and King, 1990).
Although non-invasive within the uterine lumen, pig conceptuses produce
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-several proteolytic enzymes that can erode cells when they are translocated to
tissues outside the uterine lumen (Samuel and Perry, 1972). Invasive
implantation of the proteolytic porcine conceptus is inhibited through endometrial
production of several protease inhibitors such as uterine plasmin/trypsin inhibitor
(Stallings-Mann et aI., 1994), antileukoproteinease (Simmen et aI., 1996) and
bikunin (Diederich et aI., 1997). Previously, our laboratory isolated and
characterized a glycoprotein that is homologous to inter-a.-trypsin inhibitor heavy
chain 4 (lalH4) (Geisert et al. I 1998). lal family members consist of four heavy
chain glycoproteins (H1, H2, H3, H4) and a light chain called bikunin (see review
Salier et al. , 1990). Bikunin binds with IcdH1, -H2, and -H3 and acts as a serine
protease inhibitor (see review Salier et al. , 1990). Interestingly, lalH4 does not
appear to function as a carrier for the protease inhibitor activity as it does not
bind bikunin. However, lalH4 does contain a cleavage site for the serine
protease, kallikrein (Nishimura et aI., 1995). Kallikrein has been shown to cleave
porcine plasma lalH4 into 100 and 35 kD fragments, further cleaving the 100 kD
into a 70 kD fragment (Hashimoto et aI., 1996). A 30 kO fragment corresponding
to the C-terminal of lalH4, has been detected within the uterine lumen during the
time of porcine conceptus elongation and attachment (Geisert etal., 1995).
These results suggest that kallikrein may be present within the uterine lumen of
the pig, possibly functioning to regulate alterations in lalH4 necessary for
conceptus attachment .and placentation. Therefore the objective of the current
study was to determine if endometrial kallikrein enzymatic activity, protein and
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endometrial gene expression are detectable during the estrous cycle and early
pregnancy in the pig.
Materials and Methods
Experiment I: Evaluation of Kallikrein Activity in Cyclic and Pregnant Gilts
Animals
Cyclic, crossbred gilts of similar age (8-10 mo) and weight (100-130 kg)
were checked twice daily for the onset of estrous behavior by intact boars. Onset
of estrus was consi,dered Day 0 of the estrous cycle. Gilts assigned to be mated
were bred naturally with fertile boars at the onset of estrus and 12 hours later.
Cyclic gilts (n=12) and pregnant gilts (n=11 ) were hysterectomized on either Day
10,12, and 15 as previously described by Gries et al. (1989). Following initial
induction of anesthesia with a 1.5 cc Lm. administration of a cocktail consisting
of 2.5 cc Rompum (xylazime; 100 mg/ml) (Miles, Inc., Shawnee Mission, KS),
and 2.5 cc Vetamine (ketamine HCI; 100 mg/ml) (Mallickrodt Veterinary,
Mundelein, IL) in 500 mg of Telazol (tiletamine HCI and zolazepam HCI) (Fort
Dodge, Syracuse, NE), anesthesia was maintained with a closed-circuit system
of halothane (Halocarbon Laboratories, Riveredge, NJ) and oxygen (1.0
liter/min). After exposure by midventrallaparotomy, the uterine horns and
ovaries were surgically removed. The incision site was closed using routine
surgical procedures, and gilts were treated i.m. with procaine penicillin G (20,
000 IUlkg BW).
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Collection of Uterine F1ushings and Endometrium
Uterine flushings (UTF) and endometrium were obtained by isolating one
horn and flushing with 20 ml of phosphate buffered saline (PBS; (pH 7.4).
Flushings were examined to confirm pregnancy in mated gilts. Conceptus
diameters were measured, recorded and conceptuses snap frozen in liquid
nitrogen. Uterine flushings were placed on ice, until centrifugation (2500 x g, 10
min; 4°C), and stored at -BOoC at the laboratory. After flushing, the horn was cut
along its anti-mesometrial border and endometrium was exposed for removal
with sterile scissors. Endometrium was collected, snap frozen in Iliquid nitrogen
and stored at -BOoC until RNA was extracted. The remaining uterine horn was
immediately placed in a sterile container and transported on ice to a sterile
horizontal flow hood. The uterine horn was opened along its anti-mesometrial
border and endometrium was removed from the myometrium using sterile
scissors. Endometrial strips were diced into 4x4 mm sections and a total of 0.5 g
explant tissue was placed in a 100x15 mm standard sterile petri dish (Fisher
Scientific, Pittsburgh, PA) containing 15 ml Oulbecco's modified Eagle medium
(MEM) (Gibcol Life Sciences, Gaithersburg, MO) and 2% (v/v) antibiotic-
antimycotic (Gibcol Life Sciences). To remove serum leaching from tissue,
endometrial explant cultures were initially incubated for 3 hours when media was
removed and replaced with fresh media. Endometrial explant cultures were
incubated in air on a rocking platform (4 cycles/min) for an additional 24 h in
MEM at 37°C. Endometrial explant culture media (ECM) was centrifuged (2500 x
g; 10 min) and supernatant stored at -BO°C until analyzed.
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An additional group of animals was utilized to collect endometrium for
RNA extraction. Endometrium was obtained from cyclic gilts (n=11) on Day 0, 5,
10,12,15 and 18 and Day 10,12,15, and 18 of pregnancy (n=8) as previously
described.
Experiment II: Evaluation of Concept1us Effects on Uterine Kallikrein.
Animals
Cyclic, Yorkshire gilts (n=43) of similar age and weight (100-130 kg) were
checked twice daily for the onset of estrous behavior by intact boars. Onset of
estrus was considered Day 0 of the cycle. Gilts were bred at onset of estrus and
12 hours later. In order to get a range of conceptus sizes, uterine horns were
flushed on days 10.5, 11, 11.5 and 12 of pregnancy. Gilts were anesthetized
with 12 cc Pentathol (-6 mgt kg BW; Abbott Laboratories, North Chicago, IL) via
the jugular vein. Anesthesia was maintained on a closed-circuit system of
halothane (Halocarbon Laboratories, Riveredge, NJ) and oxygen (1.0 Hter/min).
After exposure by midventrallaparotomy, the uterine horns were flushed in ,situ
with 20 ml PBS. Conceptus diameters were recorded, UTF were centrifuged,
supernatant immediately placed on dry ice, transported back to the laboratory
and stored at -BODC until analyzed for kallikrein activity and estradiol-
17~ content. The incision site was closed using routine surgical procedures, and
gilts were treated Lm. with procaine penicmin G (20, 000 IU/kg BW).
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EstradiOI-17f3 Radioimmunoassay
Estradiol-17f3 within UTF was quantified by radioimmunoassay as
previously described by Anderson et al. (1993) and validated for conceptus
estrogen in UTF by Wilson and Ford (1997). Samples (1 00 ~I) were a.ssayed in
duplicate. The sensitivity of the assay was 2 pgl tube. Multiple aliquots of a
conceptus pool were included in each assay resulting in intra- and inter-assay
coefficients of variation of 4.5% and 12.2%, respectively.
Microconcentration and Protein Determination
Uterine flushings and ECM samples were prepared for enzyme assay by
concentrating 4 ml of sample using Centricon 10 microconcentrators (Amicon,
Beverly, MA) with a molecular weight cut-off of 10,000 daltons. Protein
concentrations were determined by the method of Lowry et al. (1951).
Concentrated samples were stored at -80°C until analyzed.
Enzyme Assay
To determine the Km and Vmax of kallikrein, 5 ~I (3.75 mglml) porcine
pancreatic kallikrein (Calbiochem, La Jolla, CAl was added at varying
concentrations (21, 50, 100,250, 500 ~m) of the fluorescent substrate, Pro-Phe-
Arg-methylcoumarylamide (MCA; 0.87 mM) (Sigma, S1. Louis, MO). The reaction
was brought to a final volume of 500 III with the enzyme buffer, 0.1 M Tris-HCL
buffer containing 0.15 M NaCI, pH 8.0. The assay was performed at room
temperature in a fluorescence spectrophotometer (Perkin Elmer 650-40
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Fluorescence Spectrophotometer) with excitation at 370 nm and emission at 460
nm to measure the hydrolysis of the fluorescent product, amino methylcoumarin.
A chart recorder (Cole Palmer, Chicago, IL) recorded fluorescent activity with a
setting of 6 em/min. Each reaction was recorded for at least one minute. The Km
and Vmax of kallikrein was determined to be 300-450 IlM and 2.3.± 0.3 IlM/min,
respectively.
Prior to analysis, samples, standards and substrate were kept on ice. A
standard curve was performed prior to each assay with the addition of
aminomethyl coumarin (Sigma, St. Louis, MO) at concentrations of 0.20, 0.50,
0.75, 1.00, and 1.50 IlM in enzyme buffer. The number of fluorescent units per
standard concentration was recorded. Fluorescence of the 1.50 IlM standard
was recorded on the chart recorder for determination of fluorescent units to
mM/mV. To assay samples, 40 1..L1 concentrated UTF or ECM was added with 10
III (0.87 mM) MCA and 200 III enzyme buffer was added for a total volume of 250
Ill. The assay was performed in duplicate at room temperature with excitation at
370 nm and emission at 460 nm to measure the hydrolysis and release of the
fluorescent product, amino methylcoumarin. Chart recorder speed was 6 em/min.
Each reaction was recorded for at least one minute. Values of kallikrein activity
(mV/min) were then divided by the sample's protein content in 20 ml of uterine
flushing to give specific kallikrein activity expressed as IlM min .1/mg total
protein/ horn.
Specificity of Enzyme Assay
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Kallikrein activity in UTF and ECM was validated through addition the
synthetic kallikrein inhibitor, cyclohexylacetyl-phe-arg-ser-val-gln amide (Sigma,
St. Louis, MO). The inhibitor was added to a UTF sample of known activity.
Briefly, increasing concentrations of inhibitor (0, 1, 25, 50, 75, 100 to 200 J.1M)
were added to enzyme buffer containing 10 III of 0.87 mM MeA. After 40 J.11 of
UTF sample was added, the cuvette was immediately placed in the fluorescent
spectrophotometer, and enzyme activity recorded as previously described.
Western Blot Analysis
Uterine flushings and ECM (Experiment I) were analyzed by Western
blotting for the presence of immunoreactivity to antiserum against human plasma
kallikrein (Calbiochem, La Jolla, CA). Polypeptides in UTF and ECM (50 Ilg total
protein) were separated by 12.5% 10 SOS-PAGE (Laemmli, 1970) and
immediately transferred to PVOF membrane (Millipore Corporation, Bedford,
MA) at 150 rnA constant current for 35 min. After electroblotting, the membranes
were washed in TBS (20 mM Tris, 500 mM NaCI, pH 7.5) and incubated for 1 h
with the first blocking solution of 3% gelatin in TBS. After washing in Tween-TBS
(TIBS; 20mM Tris, 500 mM NaCI, 0.05% Tween 20, pH 7.5) for 10 minutes,
membranes were incubated overnight with the 1st antibody (1 :200 dilution) in
1% gelatin TIBS. The next day, membranes were washed twice in TIBS, twice
in TBS, and then immunoreactive polypeptides were detected using the Bio-Rad
Immuno-Blot kit (Bio-Rad, Hercules, CA) according to manufacturer's
specifications.
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RNA Extraction
TRlzol reagent (Gibco/ Life Sciences, Gaithersburg, MD) was utilized to
extract total RNA from endometrium. Briefly, 0.5 g, of endometrium was
homogenized in 5 ml TRlzol reagent using' a Virtishear homogenizer (Virtis Co.
Inc., Gardiner, NY). After the addition of 1 ml of chloroform, samples were
centrifuged for 30 min at 3500 x g (4°C). The aqueous layer was harvested and
placed into a new tube. RNA was precipitated by addition of 2.5 ml isopropanol
at room temperature. for 10 min. After centrifugation (3500 x g; 4°C) for 10 min,
supernatant was poured off. RNA pellets were washed with 5 ml 75% ethanol
and centrifuged (3500 x g) for 5 min at 4°C. RNA was rehydrated with 1OmM Tris
1mM EDTA (pH 7.4) and stored at -aOoC until further analyzed. Total RNA was
quantified specrophotometrically by absorbance at 260 nm. RNA purity was
determined from calculations of 260/280 ratios. The extraction procedure
consistently yielded 260/280 ratios of 1.7-2.0 indicating very low DNA
contamination of total RNA preparation.
Total RNA was also extracted from conceptuses from three different litters
using TRlzol reagent. Two pools of Day 12 filamentous conceptuses and one
pool of Day 12 spherical conceptuses (5 and 7 mm diameters) were analyzed.
RNA extraction was performed as previously described with the following
modifications. Filamentous conceptuses were homogenized in 1 ml TRlzol
reagent using a sterile, bulbed-end glass Pasteur pipet while spherical
conceptuses were homogenized by simply passing through a pipette tip. After
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homogenizing, 200 III of chloroform was added and centrifuged for 20 minutes at
12,000 rpm. The aqueous layer was harvested and placed into a new tube. RNA
was precipitated by addition of 500 III isopropanol. After centrifugation at 12,000
rpm for 5 min, isopropanol was removed and RNA pellets were washed with 1 ml
of 75% ethanol. Following centrifugation at 12,000 rpm for 5 min, ethanol was
removed and RNA was rehydrated in 50 III of 10 mM Tris 1 mM EDTA (pH7.4)
and stored at -BOoC until further analyzed. RNA purity was analyzed as
previously described.
Complementary DNA Preparation
Total RNA was reverse transcribed to cDNA in a Perkin Elmer Cetus
(Norwalk, CT) DNA Thermal Cycler Mode14BO. The reactions were carried out in
a total volume of 20 III containing 200 U of Moloney murine leukemia virus
reverse transcriptase-RNase H- (M-MLV-RT), 1.0 Ilg of 0Iigo(dT)1s primer, 0.5
mM each of dATP, dCTP, dGTP, dTIP, 50mM Tris-HCI (pHB.3). 75 mM KCI, 3
mM MgCl, 10 mM dithiothreitol, 20 U of RNasin, and 1.0 Jlg total RNA brought to
volume with DEPC water. The sample preparation was incubated at 22°C for 15
min and then at 42°C for 30 min. The reacUon was terminated by heating at 95°C
for 5 min and cooling to 4°C at which temperature it was stored. The M-MLV-RT,
reaction buffer, RNasin, and oligo(dThs primer were obtained from Promega
Corporation (Madison, WI).
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Kallikrein Primer, Optimization, and Sequencing
Kallikrein primers were first designed to regions of homology between the
amino acid sequence of porcine pancreatic kallikrein (Bode et al. , 1983) and
human kidney kallikrein (Baker and Shine. 1985). The nucleotide sequence of
human kidney kallikrein (bp169-603) (Baker and Shine, 1985) coinciding to
homologous amino acid regions between porcine pancreas and human kidney
was utilized to design the 5' TGACTACAGTCCACGACCTCATG and 3'
GCAGGTIGGCAGGTGCTGCC primers. All PCR reactions were carried out in
25 ~I volumes covered with 25 JlI mineral oil. To optimize PCR conditions,
pooled cDNA (from endometrium of all days cyclic and pregnant) was amplified
with 0.6 U of Taq DNA polymerase and its supplied MgCl2-free buffer (Promega,
Madison, WI) and a 3x2x3 factorial (see Table 3.1) combination of primer (50,
150, or 250 nM), deoxynucleotide triphosphates (dNTPs 50 or 100 JlM) and
MgCI 2 (1.25, 2.50, or 3.75 mM). All samples were loaded directly from ice
into the 95°C heat block to minimize time required for samples to reach
denaturation temperature. The first cycle used denaturation at 95°C for 2
mi.n, annealing at 55°C for 1 min, and a 2 min extension at 72°C. This was
followed by 34 cycles of denaturation at 95°C for 1 min, annealing at 55°C
for 1 min and a 1- min extension at 72°C. Finally, a 9 min extension at 72°C
and cooling to 4°C completed the PCR reaction. The resulting PCR product
was resolved in a 3% gel at 85 volts for 1.5 h, followed by 30 min stain in
ethidium bromide (1.0 mg/ml). The optimal conditions used for kallikrein gene
amplification were 25 mM MgCl, 100 IlM dNTPs, 250 nM primer (Figure 3.1). To
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verify PCR product as glandular kallikrein, pooled cDNA was amplified with the
previously described optimal conditions, run on a 4% agarose gel, stained with
ethidium bromide and bands were cut from the gel with a razor blade. The PCR
product was then extracted using Qiaquick (Qiagen, Santa Clarita, CA), and
sequenced by the Recombinant DNA/Protein Research Facility at Oklahoma
State University. The 109 base pair PCR product was determined to be 89%
homologous to baboon glandular kallikrein (Perelygina et aI., 1995) (Figure 3.2).
Endometrial and conceptus cDNA samples (3 I-1g) obtained across the estrous
cycle and early pregnancy were PCR as previously described. Resultant bands
were scanned in duplicate with NIH Image, Version 1.6 (NIH) densitometer.
To quantitate peR synthesis procedure for comparable amounts of
starting cDNA in samples, glyceraldehyde-3-phosphate dehydrogenase
(G3PDH) primers (Yelich et aI., 1997) were utilized. G3PDH peR products were
run in 3% agarose gels, stained and bands scanned with densitometer. A ratio of
kallikrein to G3PDH was utilized to standardize cDNA loading in each PCR
reaction.
Statistical Analysis
Data were analyzed by least-squares analysis of variance using the
General Linear Models of SAS (SAS, 1990). In Experiment I, the model used to
analyze UTF enzymatic activity and protein concentration included the effects of
day, reproductive status, the day x reproductive status interaction, gilt within day
x reproductive status and the residual (horn within gilt x day x reproductive
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status). The effects of day, reproductive status and the day x reproductive status
interaction were tested using gilt within day x reproductive status as the error
term. ECM enzymatic activity and' PCR densitometry scans were each analyzed
with a model that included the effects of day, reproductive status, and the day x
reproductive status interaction.
In Experiment II, conceptuses were classified by size as follows: <5 mm
(n=7), 5-10 mm (n=14), ovoid and tubular (n=7) and filamentous (n=15).
Kallikrein activity, estradiol-17b content and protein concentration were each
analyzed with a model that included the effects of conceptus classification. In
addition to the least-squares analyses, a Pearson correlation between estradiol
and total enzymatic activity was calculated using the Correlation procedure of
SAS (SAS, 1990).
Results
Experiment I:
Kallikrein Enzymatic Activity
Specificity of the assay for kallikrein was determined through addition of
the kallikrein inhibitor, cyclohexylacetyl-phe-arg-ser-val-gln amide. Addition of
inhibitor caused a linear decrease in kallikrein activity (Figure 3.3). Fifty percent
inhibition of enzyme activity was observed at 35 IJM, with kallikrein activity
completely abolished with addition of 200 IJM inhibitor.
There was no day x reproductive status interaction (p=O.68) in UTF
protein concentration (Figure 3.4). There was a day effect as will increases in
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total protein concentration on Day 15 (p<0.01). Total protein in UTF was similar
between Days 10 and 12 with a two fold increase in total protein on Day 15
(Figure 3.4).
There was a significant day x reproductive status interaction (p<0.001) in
enzymatic activity in UTF (Experiment I) (Figure 3.5). Kallikrein activity in UTF
increased on Day 15 of the estrous cycle and pregnancy. However, a two fold
greater activity was detected in UTF from cyclic compared to pregnant gilts. No
day x reproductive status interaction occurred in the ECM enzymatic assay
(p=0.2). However, enzymatic activity in ECM (Figure 3.6) was affected by day
(p< 0.09) and reproductive state (p< 0.05). Endometrial secretion of kallikrein
from endometrial explants was approximately 2.5 fold greater on Day 12 of
pregnancy compared to cyclic gilts. Enzyme activity in ECM declined on Day 15
of the estrous cycle and pregnancy. Although numerically greater, ECM
enzymatic activity was not statistically different between cyclic and pregnant gilts
on Day 15.
Western Blot Analysis:
Antiserum to human plasma kallikrein detected a 50 kD immunoreactive
product in UTF and ECM across Day 10 to 15 of the estrous cycle and early
pregnancy. Intensity of immunostaining was similar in Day 10, 12 and 15 UTF of
either cyclic or pregnant gilts (Figure 3.7). In UTF, a 23 kD product was usually
absent on Day 10 of the estrous cycle or pregnancy, but appeared regardless of
reproductive status on Day 12 and 15 (Figure 3.7). The 23 kD reactive product
50
appears to correspond to kallikrein activity as enzymatic activity in UTF was
associated with appearance of the immunostained band. Only the 50 kD
immunoreactive product was detected with kallikrein antiserum in ECM (Figure
3.8). Intensity of the 50 kD band was similar between cyclic and pregnant gilts.
Kallikrein Gene Expression
Endometrial gene expression of glandular kallikrein was detected on Day
0,5,10,12,15 and 18 of the estrous cycle and early pregnancy (Figure 3.9a).
Since there was only one Day 0 sample, it was deleted from the statistical
analysis. There was no reproductive status x day interaction (p=0.83) or
reproductive status effect in endometrial kallikrein gene expression. Gene
expression of endometrial kallikrein was different (p<O.OS) across the days of the
estrous cycle and pregnancy (Figure 3.9b). Densitometry analysis demonstrates
kallikrein gene expression an increase of kallikrein gene expression on Days 10
and 15. Gene expression for kallikrein was also detected in Day 12 porcine
conceptuses, muscle and kidney (Figure 3.10).
Experiment II
Content of estradiol-17p in UTF (Figure 3.11) increased (p<0.01) with
conceptus development from <5 mm spherical morphology to tubular and
filamentous conceptuses. Uterine content of estrogen increased slightly when
the uterus contained 6-10 mm spherical conceptuses with a three fold increase
when conceptuses reached a tubular morphology. Estradiol-17J3 content in UTF
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was similar between UTF which contain either tubular or filamentous
conceptuses were present in the uterine lumen. Kallikrein enzymatic activity
(Figure 3.11) was correlated (r=0.3) with estradiol-17P content (p<0.05). As
content of estradiol-17J3 in UTF increased, kallikrein enzymatic activity also
increased. Although not statistically different (p=0.7), kallikrein activity in UTF
increased two fold between <5 mm spherical to ovoid and tubular conceptuses.
However, there was almost a four fold increase (p<O.05) of kallikrein activity
when the conceptuses rapidly expanded to a filamentous morphology. Increase
in kallikrein enzymatic activity was temporally associated with an increase in
UTF total protein (Figure 3.12). Total protein in UTF increase two fold (p<0.01)
when conceptuses rapidly expanded from tubular to the filamentous stage of
development.
Discussion
Porcine conceptuses undergo a rapid morphological change from a 10mm
sphere to a thin, filamentous thread within 2-4 hours (Anderson, 1978; Geisert et
aI., 1982b) on Day 12 of gestation. During this expeditious transformation,
conceptuses produce and release estrogens to alter the uterine environment
(Geisert et aI., 1990). Alteration of endometrial secretion of proteins (Roberts et
aI., 1993), prostaglandins (Bazer and Thatcher, 1977), uterine blood-flow (Ford
et aI., 1982), uterine cellular morphology and vascular permeability (Dantzer,
1985; Keys and King, 1990) occur during conceptus elongation and estrogen
release. Despite information available on conceptus influence on the uterine
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environment, uterine factors induced by conceptus estrogen to stimulate
changes necessary for maternal recognition of pregnancy and placental
attachment have not been completely elucidated.
We have previously determined that lalH4 is present in the endometrium
of the pig (Geisert et aI., 1998). Because of the function of lalH4 in acute phase
reactions, Geisert et al. (1998) proposed that lalH4 may be involved with
attachment of the conceptus to the uterine epithelium through lalH4 association
with hyaluronate. Cleavage of IalH4 by kallikrein (Hashimoto et al., 1996) could
be involved with the timing of conceptus attachment to the uterine epithelium. It
is possible that release of kallikrein from the endometrium and/or conceptus
could regulate a number of biological events essential to conceptus
development.
The present study detected the presence of endometrial kallikrein
enzymatic activity, protein and gene expression during the estrous cycle and
early pregnancy of the pig. Kallikrein activity in UTF increased from low activity
on Day 10 to a three fold increase in activity on Day 15. Enzymatic activity was
greater in cyclic compared to pregnant gilts on Day 15. Increased levels of
kallikrein activity on Day 15 of the estrous cycle maybe caused by declining
progesterone concentrations with regression of the corpora lutea and increase in
follicular estrogen. Progesterone has a negative effect on uterine kallikrein
activity in the rat (Valdes et aI., 1996). Therefore, as plasma progesterone
concentrations decrease, kallikrein activity may increase in the pig. It is possible
that a kallikrein inhibitor may also be released from the endometrium to regulate
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kallikrein activity during pregnancy. Kallistatin, the kallikrein binding protein, has
been shown to significantly hinder kallikrein's action (Chao et aI., 1996). In ECM,
there was a significant increase of kallikrein enzymatic activity on Day 12 of
pregnancy compared to the estrous cycle. Differences in endometrial activity
suggest conceptus regulation of local kallikrein release. KaUikrein activity was
temporally related to the increase estradiol secretion from the filamentous
conceptuses. The four fold increase in kallikrein activity was associated with
conceptus elongahon through the uterine horns as there was little increase in
UTF with tubular conceptuses that contained high concentrations of estrogen.
Uterine kallikrein gene expression suggests that the endometrium is the
source of kallikrein in the uterine lumen on Day 12 of the estrous cycle and early
pregnancy. Increase of kallikrein message could cause an increase of kallikrein
synthesis and storage within the uterine epithelium. Valdes et al. (1996)
detected glandular kallikrein in secretory vesicles in the rat endometrium.
Kallikrein was released from storage vesicles after the stimulation of ovarian
estrogen on Day 5 (Valdes et aI., 1996). Production of estrogen by porcine
conceptuses would suggest a similar mechanism to release kallikrein into the
uterine lumen. The second increase in kallikrein gene expression occurs on Day
15. This time period corresponds to the second susta~ined increase in conceptus
estrogen secretion necessary for maintenance of corpora lutea function beyond
Day 30 in the pig (see Geisert et aI., 1990). The release of kallikrein suggests
that estrogen stimulates endometrial kallikrein gene expression as the
conceptus expands through the uterine horns. Estrogen stimulated release of
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kallikrein in the rat has also been proposed to be involved with blastocyst
implantation (Valdes et aI., 1996; Corthorn et aI., 1997).
Presence of kallikrein in the uterus between Day 12 to 18 may function to
cleave la.lH4. la.IH4 does not bind to the serine protease inhibitor, bikunin, as
occurs with the other 10.1 heavy chains (see Salier et aI., 1990). Rather, la.IH4
alone contains a kallikrein cleavage site (Nishimura et aI., 1995). la.IH4 contains
a von Willebrand Type-A domain which is known to bind to integrins,
proteoglycans and heparin (see Salier et al., 1990). It is possible that cleavage
of la.IH4 by kallikrein may allow trophoblastic attachment to the uterine epithelial
surface. Detection of kallikrein gene expression in the conceptus suggests
conceptus secretion of kallikrein could further regulate local effects on the
endometrium.
Presence of kallikrein activity in the uterus indicates a functional
kallikrein-kininogen-kinin system exists in the porcine uterus as been
documented in the uterus of rodents (Brann et aI., 1995; Valdes et aI., 1996).
Tissue kallikrein cleaves low molecular weight kininogen and rel,eases kinins,
namely bradykinin (see Shoola et al., 1992). Kinins have many bioactive
properties, including increased blood flow, decreased membrane permeability,
contraction of smooth muscle, release of calcium and release of prostaglandins
(Cooper et aI., 1985; Shoola et aI., 1992) all of which occur during the time of
porcine conceptus elongation and implantation (see Geisert et al., 1990).
Bradykinin has also been known to stimulate interleukin (IL) -6 and IL-8
secretion from human decidua derived cells (Rehbock et aI., 1997). Mathialagan
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et al. (1992) indicated that IL-6 is secreted from porcine conceptuses between
Day 13-17. Furthermore, IL-6 upregulates lal heavy chains -1, -2, and -3 which
also contain a von Willibrand type A domain (see Salier et al., 1996). Therefore,
it is possible that kallikrein functions to cleave low molecular weight kininogen
releasing bradykinin on Day 12, which stimulates IL-6 release from porcine
conceptuses to upregulate lal members for conceptus attachment to the uterine
epithelial surface.
Increase in kallikrein activity could also playa role in regulating insulin-
like growth factor (IGF) activity within the uterine lumen. Simmen et al. (1989)
indicated a substantial increase in IGF-I occurs within the uterine lumen on Day
12 of pregnancy in the pig. Activity of IGFs is regulated by IGF binding proteins
(IGFBP) (see Simmen et al.,1995). Kallikrein has been demonstrated to cleave
IGFBPs (Cohen et aI., 1992; Rajah et aI., 1996). Prostate specific antigen (P5A)
is form of glandular kallikrein in the human (see Bhoola et aI., 1992) that cleaves
IGFBP-3 (Cohen et aI., 1992). Insul,in-like growth factor BP3, BP4, BP5 and BP6
is cleaved by 75 nerve growth factor, another form of glandular kallikrein (Rajah
et aI., 1996).
Lee and coworkers (1998) demonstrated the disappearance of high
affinity IGFBPs in UTF of pigs on Days 11 and 12 of pregnancy. As porcine
conceptuses reach the filamentous stage, IGFBP-3 is completely abolished.
When aprotinin, a serine protease inhibitor, is added to reactions, IGFBP
protease activity is inhibited. Furthermore, when a specific inhibitor for
plasminogen activator (a serine protease) is added, IGFBP protease activity is
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not hindered. IGFBP have also been shown to be cleaved by metalloproteinases
(MMPs; Fowlkes et aI., 1994), but UTF IGFBP proteolysis was not stopped when
MMP inhibitors were added (Lee et aI., 1998). By eliminating plasminogen
activitor as a candidate for the serine protease involved, as well as MMPs,
kallikrein activity may very well be the protease controlling IGFBP proteolysis.
Evidence that kallikrein in the porcine lumen increases in activity at
crucial stages in conceptus survival, suggests kallikrein may be a key regulator
in biological processes coincident with conceptus elongation and trophoblast
attachment. Estrogen appears to dictate kallikrein gene expression and kallikrein
release in the porcine uterus as has been reported in the rat (Valdes et aI.,
1996; eorthom et aI., 1997). Further investigations are needed to determine the
processes that kallikrein is involved with during the time of maternal recognition
of pregnancy in the porcine uterus.
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Table 3.1. Conditions for PCR optimization with changes in primer,
dNTPs, and MgCI.
Lane Primer (5 J.LM stock) dNTPs (10 mM stock) 10 x MgCI
1 0.5 JlI 0.5 ul 1.25 ull
2 0.5 0.5 2.50
3 0.5 0.5 3.75
4 0.5 1.0 1.25
5 0.5 1.0 2.50
6 0.5 1.0 3.75
7 1.5 0.5 1.25
8 1.5 0.5 2.50
9 1.5 0.5 3.75
10 1.5 1.0 1.25
11 1.5 1.0 2.50
12 1.5 1.0 3.75
13 2.5 0.5 1.25
14 2.5 0.5 2.50
15 2.5 , 0.5 3.75
16 2.5 1.0 1.25
17 2.5 1.0 2.50
18 2.5 1.0 3.75
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Figure 3.1. Photograph of an ethidium bromide stained 3% gel with peR
products from kallikrein primer optimization. Conditions utilized for
amplification of kallikrein in Lane 5 (see Table 3.1) were selected for
analysis of gene expression in porcine endometrium. Arrow indicates
proper band size (-150 bp). (-) indicates negative control (no cDNA
added). M represents the marker lane.
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Figure 3.2. Nucleotide sequencing of the 150 bp peR product is 89%
homologous to baboon glandular kallikrein. p indicates the porcine
sequence; b indicates the baboon sequence with black color as
homologous base pairs.
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p3 actacagtcc acgacctcat gctgctccgc
b353 actacag-cc acgacctcat gctgctccgc
p33 ctgacgcagc ccgccgccaa gatcacagac
b383 ctgcag-·agc ccgccgccga gatcacagac
p63 gctgtgaagg tcctggagct gcccacccag
b403 gctgtgcagg ttgtggagtt gcccacccag
p93
b433
gaacccgaactgggcagcacctg
gaacccgaagtggggagcacctg
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Figure 3.3. Kallikrein activity in a Day 15 cyclic gilt UTF following addition of
various concentrations of the kallikrein inhibitor, cyclohexylacetyl-phe-
arg-ser-val-gln amide.
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Figure 3.4. Protein concentration in uterine f1ushings from Experiment I.
Yellow bars indicate cyclic animals; Blue bars indicate pregnant
animals. No significant day x reproductive status interaction was
detected (p=O.78). An effect of day was detected (p<O.01).
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Figure 3.5. Kallikrein proteolytic activity in porcine UTF from cyclic (yellow bars)
and pregnant (blue bars) gilts. Columns with different superscripts are
significantly different (p<O.001). Number of animals are in parenthesis.
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Figure 3.6. Kallikrein proteolytic activity in porcine ECM from cyclic (yellow bars)
and pregnant (blue bars) gilts. Significant difference by Day (p<O.09)
and reproductive status (p<O.05) were detected. Number of animals
are indicated in parenthesis.
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15
Figure 3.7. Representative Coomassie Blue staining (A) of uterine f1ushings
during the estrous cycle (C) and early pregnancy (P) and Western
Blot analysis (B) using human plasma anti-kallikrein. Human plasma
used as a (+) control.
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Figure 3.8. Representative Coomassie Blue staining (A) of explant culture media
during the estrous cycle (C) and early pregnancy (P) and Western
Blot analysis (B) using human plasma anti-kallikrein. Human plasma
used as a (+) control.
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Figure 3.9a. Representative peR using kallikrein primers to express endometrial
cDNA across the estrous cycle (C) and early pregnancy (P). (-)
indicates negative control (no cDNA added).
b. Densitometry analysis of PCR using kallikrein primers on porcine
endometrial cDNA samples. A significant day effect was present
(p<O.05). Number of animals indicate in parenthesis.
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Figure 3.10. peR using kallikrein primers on porcine endometrium (E), conceptus
(C), muscle (M) and kidney (K) cDNA. (-) indicates negative control
(no cDNA added).
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Figure 3.11. Comparison of kallikrein activity and estradiol-17~ content in UTF
containing different conceptus morphologies. Conceptuses ranges
include: <5 mm, 5-10 mm, ovoid and tubular (OIT"), and
filamentous (F). There was a significant increase in estradiol-17~
(red bars) (p<O.01) and kallikrein activity (yellow bars) (p<O.OS).
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Figure 3.12. Comparison of protein concentration in uterine f1ushings containing
different conceptus morphologies. Conceptuses ranges include: <5
mm, 5-10 mm, ovoid and tubular (Orr), and filamentous (F). There
was a significant increase in protein concentration when
conceptuses were filamentous (p<O.001).
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CHAPTER IV
Detection of endometrial low molecular weight kininogen secretion and gene
expression during the estrous cycle and early pregnancy in gilts.
Introduction
The kallikrein-kininogen-kinin system is involved in inflammatory
processes that occur throughout the body (see Shoola et aI., 1992; Clements et
aI., 1997). An inflammatory response in tissue is characterized by increased
vasodilation, vascular permeability and edema (Clements et aI., 1997). Along
with mast cell activation and neutrophil invasion, prostaglandins and various
growth factors playa role in kallikrein-kininogen-kinin mediated events (Shoola et
aI., 1992).
Many reproductive processes including endometrial proliferation, ovulation
and decidualization have been suggested to mirror inflammatory reactions
(Clements et aI., 1997). Various growth factors, prostaglandins and cytokines are
known to playa role in these reproductive actions (Shoola et al., 1992; Clements
et al., 1997). It is logical that biologic processes involved in endometrial
proliferation, ovulation (Gao et ai, 1992) and decidualization (Valdes et aI., 1996)
may be similar to those involved in inflammatory responses.
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During the period of maternal recognition of pregnancy until the time of
conceptus attachment, many changes occur within the porcine uterine lumen to
permit conceptus attachment and growth. Porcine conceptuses morphologically
change from 10 mm spheres to long, filamentous threads in 2-4 hours on Day 12
of pregnancy (Geisert et aI., 1982b). During this period of conceptus growth and
elongation, conceptuses synthesize and release estrogens (Gadsby et al., 1980;
Fischer et aI., 1985; Mondschein et at, 1985) to initiate maintenance of CL
function and uterine secretion necessary for conceptus attachment and growth.
Endometrial prostaglandin release is changed from an endocrine to an exocrine
direction (Bazer and Thatcher, 1977), as well as there is an increase in uterine
blood-flow (Ford et aI., 1982), uterine smoo~h muscle contraction, and vascular
permeability (Keys and King, 1990). Kallikrein enzymatic activity, protein and
gene expression have been detected within the porcine uterus (Chapter 3).
Presence of kallikrein may regulate cleavage of inter-a.-trypsin inhibitor heavy
chain 4 (laIH4), which has been proposed to assist with conceptus attachment to
the uterine epithelium (Geisert et aI., 1998). Tissue kallikrein may also function to
utilize its natural substrate, low molecular weight kininogen, to release the potent
vasoactive peptide, bradykinin (Bhoola et aI., 1992). Kinin production has been
associated with increased prostaglandin production, increased blood flow and
increased smooth muscle contraction (see review Bhoela et aI., 1992), all of
which occur during establishment of pregnancy in the' pig. The objective of the
current study is to investigate gene expression of low molecular weight kininogen
in porcine endometrium as well as presence of low molecular weight kininogen in
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the uterine f1ushings and explant culture media throughout the estrous cycle and
early pregnancy in the pig.
Materials and Methods
Animals
Cyclic, crossbred gilts of similar age (8-10 mo) and weight (100-130 kg)
were checked twice daily for the onset of estrus behavior by intact boars. Onset
of estrus was considered Day 0 of the estrous cycle. Gilts assigned to be mated
were bred naturally with fertile boars at the onset of estrus detection and 12
hours later. Cyclic (n=12) and pregnant gilts (n=11) gilts were hysterectomized
on either Day 10, 12, and 15 as previously described by Gries et al. (1989).
Following initial induction of anesthesia with a 1.5 cc Lm. administration of a
cocktail consisting of 2.5 cc Rompum (xylazime; 100 mg/ml) (Miles, Inc.,
Shawnee Mission, KS), 2.5 cc Vetamine (ketamine HCI; 100 mg/ml) (Mallickrodt
Veterinary, Mundelein, IL) in 500 mg of Telazol (tiletamine HCI and zolazepam
HCI) (Fort Dodge, Syracuse, NE), anesthesia was maintained with a closed-
circuit system of halothane (Halocarbon Laboratories, Riveredge, NJ) and
oxygen (1.0 liter/min). After exposure by midventrallaparotomy, the uterine horns
and ovaries were surgically removed. The incision site was closed using routine
surgical procedures, and gilts were treated Lm. with procaine penicillin G (20,000
lU/kg BW).
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Collection of Uterine Flushings and Endometrium
Uterine f1ushings (UTF) and endometrium were obtained by isolating one
horn and flushing with 20 ml of phosphate buffered saline (PBS; pH 7.4).
Flushings were examined to confirm pregnancy in mated gilts. Conceptus
diameters were measured, recorded and conceptuses snap frozen in liquid
nitrogen. Uterine f1ushings were placed on ice, until centrifugation (2500 x g, 10
min; 4oC), and stored at -BOoC at the laboratory. After flushing, the horn was cut
along its anti-mesometrial border and endometrium exposed for removal with
sterile scissors. Endometrium was collected, snap frozen in liquid nitrogen and
stored at -BOoC until RNA extraction was performed. The remaining uterine horn
was immediately placed in a sterile container and transported on ice to a sterile
horizontal flow hood. The uterine horn was opened along its anti-mesometrial
border and endometrium was removed from the myometrium using sterile
scissors. Endometrial strips were diced into 4x4 mm sections and a total of 0.5 9
explant tissue was placed in a 100x15 mm standard sterile petri dish (Fisher
Scientific, Pittsburgh, PAl containing 15 ml Dulbecco's modified Eagle medium
(MEM) (Gibco/ Life Sciences, Gaithersburg, MO) and 2% (v/v) antibiotic-
antimycotic (Gibco/ Life Sciences). To remove serum leaching from tissue,
endometrial explant cultures were initially incubated for 3 hours when media was
removed and replaced with fresh media. Endometrial explant cultures were
incubated in air on a rocking platform (4 cycles/min) for an additional 24 h in
MEM at 37°C. Endometrial explant culture media (ECM) was centrifuged (2500 x
g; 10 min) and supernatant stored at -BO°C until analyzed.
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Additional animals were hysterectomized as previously described from
cyclic gilts (n=11) on Day 0, 5, 10, 12, 15 and 18 and Day 10, 12. 15, and 18 of
pregnancy (n=8). Endometrium was extracted from all animals for RNA analysis,
whereas UTF from Day 0 and 5 cyclic were used in Western Blot Analysis.
Microconcentration and Protein Determination
Uterine f1ushings and ECM samples were prepared for enzyme assay by
concentrating 4 ml of sample using Centricon 10 microconcentrators (Amicon,
Beverly, MA) with a molecular weight cut-off of 10.000 daltons. Protein
concentrations were determined by the method of Lowry et al. (1951).
Concentrated samples were stored at -80°C until analyzed.
Western Blot Analysis
Uterine f1ushings and ECM were analyzed by Western blotting for the
presence of immunoreactivity to antiserum against human low molecular weight
(LMW) kininogen (Biogenesis, England, UK). Polypeptides in UTF and ECM (50
~g total protein) were separated by 12.5% 10 SOS-PAGE (Laemmli, 1970) and
immediately transferred to PVOF membrane (Millipore Corporation, Bedford, MA)
at 150 rnA constant current for 35 min, After electroblotting, the membranes were
washed in TBS (20 mM Tris. 500 mM NaCl, pH 7.5) and incubated for 1 h with
the first blocking solution of 3% gelatin in TBS. After washing in Tween-TBS
(TTBS; 20mM Tris, 500 mM NaCl, 0.05% Tween 20. pH 7.5) for 10 minutes,
membranes were incubated overnight with the 1st antibody (1 :200 dilution) in 1%
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and then immunoreactive polypeptides were detected using the Bio-Rad
Immuno-Blot kit (Bio-Rad, Hercules, CAl according to manufacturer's
specifications.
RNA Extraction
TRlzol reagent (Gibcol Life Sciences, Gaithersburg, MD) was utilized to
extract total RNA from endometrium. Briefly, 0.5 g of endometrium was
homogenized in 5 ml TRlzol reagent using a Virtishear homogenizer (Virtis Co.
Inc., Gardiner, NY). After the addition of 1 ml of chloroform, samples were
centrifuged for 30 min at 3500 x 9 (4°C). The aqueous ,layer was harvested and
placed into a new tube. RNA was precipitated by addition of 2.5 ml isopropanol at
rt. for 10 min. After centrifugation (3500 x g; 4°C) for 10 min, supernatant was
poured off. RNA pellets were washed with 5 ml 75% ethanol and centrifuged
(3500 x g) for 5 min at 4°C. RNA was rehydrated with 10mM Tris 1mM EDTA (pH
7.4) and stored at -aooe until further analyzed. Total RNA was quantified
spectrophotometrically by absorbance at 260 nm. RNA purity was determined
from calculations of 260/280 ratios. The extraction procedure consistently yielded
260/280 ratios of 1.7-2.0 indicating very low DNA contamination of total RNA
preparation.
Total RNA was also extracted from conceptuses from three different litters
using TRlzol reagent. Two pools of Day 12 filamentous conceptuses and one
pool of Day 12 spherical conceptuses (5 and 7 mm diameters) were analyzed.
88
I
.',
I ,
,
;.
RNA extraction was performed as previously described with the following
modifications. Filamentous conceptuses were homogenized in 1 ml TRlzol
reagent using a sterile, bulbed-end glass Pasteur pipet while spherical
conceptuses were homogenized by simply passing through a pipette tip. After
homogenizing, 200 ~I of chloroform was added and centrifuged for 20 minutes at
12,000 rpm. The aqueous layer was harvested and placed into a new tube. RNA
was precipitated by addition of 500 ~I isopropanol. After centrifugation at 12,000
rpm for 5 min, isopropanol was removed and RNA pellets were washed with 1 ml
of 75% ethanol. Following centrifugation at 12,000 rpm for 5 min, ethanol was
removed and RNA was rehydrated in SO JlI of 10 mM Tris 1mM EDTA (pH7.4)
and stored at -BOoC until further analyzed. RNA purity was analyzed as
previously described.
Complementary DNA Preparation
Total RNA was reverse transcribed to cDNA in a Perkin Elmer Cetus
(Norwalk, CT) DNA Thermal Cycler Model 480. The reactions were carried out in
a total volume of 20 ~I containing 200 U of Moloney murine leukemia virus
reverse transcriptase-RNase H- (M-MLV-RT), 1.0 ~g of 01:igo(dT)15 primer, 0.5
mM each of dATP, dCTP, dGTP, dTTP, 50mM Tris-HCI (pH8.3), 75 mM KCI, 3
mM MgCI, 10 mM dithiothreitol, 20 U of RNasin, and 1.0 ~g total RNA brought to
volume with DEPC water. The sample preparation was incubated at 22°C for 15
min and then at 42°C for 30 min. The reaction was terminated by heating at 95°C
for 5 min and cooling to 4°C at which temperature it was stored. The M-MLV-RT,
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reaction buffer, RNasin, and 0Iigo(dT)15 primer were obtained from Promega
Corporation (Madison, WI).
LMW Kininogen Primer, Optimization, and Sequencing
LMW kininogen primers were designed to bovine (Nawa et al., 1983; bp
401-954) and mouse (Takano et aI., 1996; bp 295-851) low molecular weight
kininogen (5': TGGCAGGACTGTGACT; 3'GCTGGCTCTGCCCCTGCCT). All
PCR reactions were carried out in 25 III volumes covered with 25 III mineral oil.
To optimize PCR conditions, pooled cDNA (from endometrium of all days cyclic
and pregnant) was amplified with 0.6 U of Taq DNA polymerase and its supplied
MgCb-free buffer (Promega, Madison, WI) and a 3x2x3 factorial combination
(see Table 3.1) of primer (50, 150, or 250 nM), deoxynucleotide triphosphates
(dNTPs 50 or 100 IlM) and MgCb (1.25,2.50, or 3.75 mM). All samples were
loaded directly from ice into the 95°C heat block to minimize time required for
samples to reach denaturation temperature. Touchdown PCR was utilized to
amplify the LMW kininogen gene. The first cycle used denaturation at 95°C for 2
min, annealing' at 65°C for 1 min, and a 2 min extension at 72°C. This was
followed by 28 cycles of denaturation at 94°C for 1 min, annealing starting at
64°C and dropping 0.50C each cycle for 1 min and a 2 min extension at 72°C.
Nine more cycles were performed with denaturing for 1 min at 94°C, annealing
for 1 min at 50°C and extension for 2 min at 72°C. PCR was completed by
cooling to 4°C. The resulting PCR product was resolved in a 3% g;el at 85 volts
for 1.5 h, followed by 30 min stain in ethidium bromide (1.0 mg/ml). The optimal
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conditions used for kallikrein gene amplification were 25 mM MgCl, 50 IlM
dNTPs, 250 nM primer (Figure 4.1). To verify peR product as low molecular
weight kininogen, pooled cDNA was amplified with the previously described
optimal conditions, run on a 3% agarose gel, stained with ethidium bromide and
bands were cut from the gel with a razor blade. The peR product was then
extracted using Qiaquick (Qiagen, Santa Clarita, CA), and sequenced by the
Recombinant DNA/Protein Research Facility at Oklahoma State University. The
409 base pair PCR product sequence was 83% homologous (Figure 4.2) to
bovine LMW kininogen (Nawa et aI., 1983), Endometrial cDNA samples (1 J.lg)
obtained across the estrous cycle and early pregnancy were PCR as previously
described. Resultant bands were scanned in duplicate with NIH Image, Version
1.6 (NIH) densitometer.
To quantitate PCR synthesis procedure for comparable amounts of
starting cDNA in samples, glyeeraldehyde-3-phosphodehydrogenase (G3PDH)
primers (Yelich et aI., 1997) were utilized. G3PDH PCR products were run in 3%
agarose gels, stained and bands scanned with densitometer. A ratio of LMW
kininogen to G3PDH was utilized to standardize eDNA loading in each peR
reaction.
Statistical Analysis
PCR and Western blot densities were analyzed with least squares
methods using the General Linear Models procedure of SAS (SAS, 1990). The
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model included the effects day, reproductive status, and the day x reproductive
status interaction.
Results
Western Blot Analysis
Western blot analysis detected a -66 kD immunoreactive product in both
the ECM (Figure 4.3) and UTF (Figure 4.4) across all days of the estrous cycle
and early pregnancy. No visual differences of LMW kininogen were observed in
ECM did between days of the estrous cycle or pregnancy (Figure 4.3). Although
densitometry analyses of UTF LMW kininogen approached a tendency for a
reproductive status x day interaction (p=0.2), there was an effect of day (p<O.OS).
Although not statistically different, LMW kininogen density was numerically lower
in pregnant versus cyclic UTF on Day 1S.
Touchdown PCR
The 400 bp product for LMW kininogen gene expression was detected
across all days of the estrous cycle and early pregnancy (Figure 4.6). No
difference in gene expression was detected when densitometry scans of the
LMW kininogen gene product were adjusted for the housekeeping gene, G3PDH.
Gene expression for LMW kininogen was also detected in porcine conceptus
pools, muscle and kidney (Figure 4.7).
Discussion
Many reproductive events mimic immunological responses (Clements et
aI., 1997). Biologic processes involved in endometrial proliferation, ovulation
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(Gao et ai, 1992) and decidualization (Valdes et aI., 1996) reflect the
inflammatory response, During the time of maternal recognition of pregnancy
unt.il the time of conceptus attachment, many events occur in the porcine uterine
lumen, which are similar to inflammatory responses. The porcine conceptus
morphologically changes from a 10 mm sphere to a long filamentous thread in 2-
4 hours on Day 12 of pregnancy (Geisert et aI., 1982b). With rapid elongation
and growth of the conceptus, estrogen synthesis by conceptuses can alter
uterine secretion of proteins (Roberts et aI., 1993), prostaglandins (Bazer and
Thatcher, 1977), uterine blood-flow (Ford et al., 1982), uterine cellular
morphology (Geisert et aI., 1982b) and vascular permeability (Keys and King,
1990) as it covers the uterine surface. Porcine endometrial release of kaUikrein
(Chapter 3) may be involved with cleavage of inter-a-trypsin inhibitor heavy chain
4 (1cxIH4), which is found in the porcine uterus (Geisert et al., 1998). Cleavage of
lalH4 may be important for opening the implantation window for conceptus
attachment Tissue kallikrein may also cleave its natural substrate, low molecular
weight kininogen, to release the potent vasoactive peptide, bradykinin. Kinin
production has been associated with increased prostaglandin production,
increased blood flow and increase smooth muscle contraction (see review
Bhoola et aI., 1992), all of which occur during maternal recognition of pregnancy
and conceptus attachment in the gilt.
The present study clearly demonstrates that LMW kininogen is present in
porcine uterine flushings, and endometrial tissue throughout the estrous cycle
and early pregnancy. Endometrial gene expression of LMW kininogen does not
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differ throughout the estrous cycle or pregnancy when adjusted for G3PDH gene
expression. Although not statistically different, Day 15 pregnant LMW kininogen
levels appeared to decline. Levels of detectable LMW kininogen may be
decreased due to an increase in kallikrein activity on day 15 (Chapter 3).
Increase in kallikrein would cause more kinin to be liberated, and therefore
providing the important biological effects necessary for establishing an
environment permissive to conceptus development.
Endometrial gene expression and protein secretion of LMW kininogen
appears to be constitutive as no difference was detected across the days of the
estrous cycle or pregnancy. Kininogen must always be available in a moment of
trauma andl or inflammatory response in order for kinins to be liberated (see
Bhoola et ai, 1992). Therefore, the key regulator of LMW kininogen function to
release kinin in the porcine uterus is the release of kallikrein. Through kallikrein
regulation, kinin acts to perform the biological processes that are present in the
uterus (i.e. increased blood-flow, vascular permeability, smooth muscle
contraction). Blood flow to the pregnant uterine horn is increased on Day 12 and
13 compared to the nongravid horn in unilateral pregnancies (Ford and
Christenson, 1979). Ford et al. (1982) documented that Day 13 gravid horns had
higher uterine blood flow, as weH as greater uterine lumena.1 concentrations of
estrogen compared to nonpregnant females. In the rat there is an increase in
estrogen (Brann et aI., 1995; Valdes et aI., 1996) that is associated with an
increase in uterine kallikrein activity, thus increased kinin release. The increase
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in blood flow that is detected on Days 12 of pregnancy, may be due to estrogen's
action to stimulate kinin release.
Porcine conceptuses were also demonstrated to have LMW kininogen
gene expression as detected through PCR analysis. If LMW kininogen is
translated, al10ng with glandular kallikrein (see Chapter 3), the conceptus itself
may liberate kinins, thus having a local effect on the uterine epithelium in which it
is contacting. Thus, endometrial as well as conceptus sources may be
contributing to kinins in the uterine lumen.
Kininogens contain a domain known to inhibit cathepsin L (Coleman,
1996; Schmaier, 1997). Cathepsin L is proteolytic and has a high affinity for
collagen (Kirschke et aI., 1982). Geisert et al. (1997) demonstrated an increase
of cathepsin-L activity in porcine UTF on Day 15 of the estrous cycle and
pregnancy. This corresponds to the time when LMW kininogen was decreased in
porcine UTF in this study. The increase that Geisert et al. (1997) documented
may have been due to a decline in cathepsin L's inhibitor, LMW kininogen.
Presence of LMW kininogen and kallikrein (see Chapter 3) in the porcine
uterus indicate that the kininogen-kallikrein-kinin system is biologically active
during establishment of pregnancy in the pig. The role that the kallikrein-
kininogen -kinin system is playing in the porcine uterus may direct numerous
events that are necessary for conceptus survival. Future studies will establish if
conceptus estrogen acts through the kallikrein-kininogen-kinin system to
establish pregnancy and provide an environment for continued conceptus growth
and survival.
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Figure 4.1. Photograph of an ethidium bromide stained 3% gel with PCR
products from LMW kininogen primer optimization. Conditions used in
further analysis are those of Lane 4 (see Table 3.1). Arrow indicates
proper band size (-400 bp). (-) indicates negative control (no cDNA
added). M represents the marker lane.
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Figure 4.2, Nucleotide sequencing of the 400 bp peR product is 83%
homologous to bovine LMW kininogen. p indicates the porcine
sequence; b indicated the bovine sequence with black color as
homologous base pairs.
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p6 cccagacctg gaggagcctc taaac-attc catcgccaag
b901 cccagacctg gaggagcctc tgagccattc catcgeaaag
p46 cttaatgcag agaacaatgc agtcttctat ttc--gattg
b941 cttaatgcag agcatgatgg agccttctat ttcaagattg
pB6 acct tgtgga aaaagcaaca gtacaggtgg tggctggnnn
b981 acactgtgaa aaaagcaaca gtacaggtgg tagctgga t t
p126 nnnntattet attggtgttc acggccaggg aaaccacatg
b1 011 gaagtattct attg-tgttc atagcaaggg aaaccacatg
p166 ttccaagcaa agtaatgaag ag gacaga aagttgtgag
b1051 ttctaaggga agtaat9aag agctgaccaa gagttgtgag
p206 atcaagaaac ctggtcaaat tctaaagtgt aatgc ctg
b1091 atcaatatac atggtcaaat teta~actgt gatgctaatg
p246 tttacgtggt acettgggag nnnnnnntct accctaetgt
b1131 tctatgtggt gccttgggag gaaaaagt accctactgt
p2B6 caaatgtcaa ttaettggac agaectcact gatgaaaagg
b1171 caactgtcaa ccacttggac agacetcact catgaaaagg
p326 cctccaggtt tttcaccttt ccgatcagta caagtggaga
b1211 cctccgggtt tttcaccttt ccgatcagtt caagtgatga
p366 aaact
b1261 aaact
99
",
..
..
'\
."
.0,
0,
"
"
."
'It
~I~h.
":~
.,. ~
.,1
"
~
'.
;;1
".
Figure 4.3. Coomassie Blue staining (A) of explant culture media
during the estrous cycle (C) and early pregnancy (P) and Western
Blot analysis (B) using human LMW kininogen. M indicates marker
lane. Arrow indicates 66 kD immunoreactive product.
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Figure 4.4. Representative Coomassie Blue staining (A) of uterine flushings
during the estrous cycle (C) and early pregnancy (P) and Western
Blot analysis (B) using human LMW kininogen. M indicates marker
lane. Arrow indicates 66 kD immunoreactive product.
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Figure 4.5. Densitometry analysis of Western blot analysis using antibody to
LMW kininogen in UTF on cyclic (C) and pregnant (P) gilts. Yellow
bars indicate cyclic animals. Blue bars indicate pregnant animals.
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Figure 4.6. Representative PCR using, LMW kininogen primers to express
endometrial cDNA across the estrous cycle (C) and early pregnancy
(P). (-) indicates negative control (no cDNA added).
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Figure 4.7. PCR using LMW kininogen primers on porcine endometrium (E),
conceptus(C), muscle (M) and kidney (K) eDNA. (-) indicates
negative control (no eDNA added).
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CHAPTER V
General Discussion
In domestic species, such as the pig, cow, and ewe, implantation is a
relatively late event when compared to rodents and humans. The early embryo is
first nourished by uterine milk until its demands for nutrition drive it to seek other
sources, nourishment from the maternal side. Establishment of placentation is a
necessary event for a successful pregnancy. In order to establish its placenta,
the porcine conceptus undergoes a rapid morphological transformation on day 12
(Anderson et a/., 1978, Geisert et a/., 1982b). After attaining -10mm in diameter,
the porcine conceptus elongates into a long, filamentous thread in the course of
2-4 hours without an increase in cell number (Geisert et aL, 1982b; Pusateri et
aI., 1990). During this process, the conceptus releases estrogens to act as the
maternal recognition of pregnancy across the endometrium in the pig (see
Geisert et aI., 1990). Conceptus estrogens influence uterine protein secretion
(Roberts et aI., 1993), redirect prostaglandin release from an endocrine to an
exocrine direction (Bazer and Thatcher, 1977), increased uterine blood-flow
(Ford et aI., 1982) and altered uterine cellular morphology (Geisert et al., 1982b;
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Keys and King, 1990). Estrogen is imperative for these events to occur, not only
on day 12, but a second sustained conceptus estrogen release is essential on
day 15 to maintain long term corpora lutea function. Knowledge of the effects that
estrogens are having on the uterine dynamics remains unclear, i.e. estrogens
may be directly or indirectly influencing a physiological process.
On day 13, the porcine conceptus begins to attach to uterine epithelium in
order to establish its placenta. Unlike other species that actively invade through
the uterine epithelium, implantation by the pig conceptus is non-invasive and
forms the diffuse, epitheliochorial placenta (Keys and King, 1990). The nature of
porcine conceptuses is proteolytic if the porcine conceptus is placed outside the
uterine lumen, as it will actively invade into the surrounding tissue (Samuel and
Perry, 1972). Therefore the porcine endometrium must produce proteolytic
inhibitors. Trophoblastic attachment to the uterine surface epithelial glycocalyx
present on the microvilli provides close contact between the maternal
endometrial surface and the conceptus to establish. placental attachment and
attainment of nutrients (Keys and King, 1990). Before the conceptus can attach,
the uterine surface epithelium must be altered to anow for close contact with the
conceptus. The opening of the "implantation window" is necessary for successful
placental establishment.
One of the major factors that hinder attachment in the pig is the
glycoprotein, Muc-1 (Bowen et aI., 1996, 1997). When Muc-1 is depleted from
the glycocalyx, attachment can occur through extracellular matrix proteins
binding to integrins on the uterine surface (Hynes, 1992). Other glycoproteins are
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also present on the glycocalyx, including led family members (Geisert et aI.,
199B). After initial contact between conceptus and uterine epitheli.um, the
extracellular matrix needs to be stabilized. lal family members play an important
role in extracellular matrix stabilization (Bost et aI., 199B). Hyaluronic acid makes
up a large majority of the extracellular matrix and is present on the trophoblastic
surface.
Geisert et al. (199B) have found lalH4 to be present in the porcine uterus.
Similar to other lal heavy chains, ialH4 contains a von Willibrand domain which
is known to bind to integrins and heparin (see Salier et aI., 1992) and therefore
has been proposed to be involved with attachment. However lalH4 is unique as it
does not bind the serine protease inhibitor bikunin (see Salier et aI., 1992),
therefore possesses no proteolytic activity. Even more interesting, lalH4 contains
a cleavage site for the serine protease, kallikrein (Nishimura et aI., 1995).
Kallikrein has been shown to cleave lalH4 in porcine plasma to release a 100
and 30 kD fragments with further cleaving of the 100 kD to 70 kD (Hashimoto et
aI., 1996). Geisert et al. (1995) have detected a 30 kD fragment in the por~ine
uterus, therefore it is possible that kallikrein activity is present in the uterine
lumen.
The present study detected kallikrein activity, protein and gene expression
in the porcine lumen during the estrous cycle and early pregnancy in the pig.
Kallikrein activity in pregnant UTF was elevated over cyclic animals on day 12,
and a three-fold increase was measured on day 1S with cyclic animals having
greater activity than pregnant gilts. Kallikrein levels have been known to be
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regulated by ovarian hormones (Brann et aI., 1995; Valdes et aI., 1996), with
progesterone hindering kallikrein activity and estrogen stimulating activity. On
day 15 of the estrous cycle, the corpora lutea are regressing and follicles are
beginning to grow, thus plasma concentrations of progesterone are declining with
increasing concentrations of estrogen. This may be the reason for the increased
kallikrein activity seen on day 15 of the estrous cycle. In order to better
understand the role ovarian hormones play on kallikrein activity in the pig,
ovariectomized gilts receiving estrogen, progesterone, and estrogen and
progesterone treatments need to be eval.uated. This will provide a clearer picture
of how kallikrein is regulated under the influence of ovarian steroids. Besides
hormonal regulation, another regulator of kalli.krein is its binding protein,
kallistatin (Chao et aI., 1996). Protein and gene expression for kallistatin also
needs to be investigated. It makes sense that the uterus would inhibit the serine
protease, kallikrein, by producing a binding protein as seen with plasmin and
metalloproteinases.
In ECM, there was a significant increase of kallikrein activity on Day 12 of
pregnancy compared to the estrous cycle. Differences in endometrial activity
suggest that the conceptus may regulate local kallikrein release. This is verified
with the kallikrein activity detected in UTF containing different conceptus sizes.
Kallikrein activity was related to the increase in estradiol secretion from the
filamentous embryos. Although no difference was detected in estradiol
concentration between tubular and filamentous conceptuses, there was a four
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fold increase in kallikrein activity only when conceptuses elongated throughout
the uterine horn.
Detection of gene expression in endometrium suggests that the lumenal
source of kallikrein is from the uterus. Kallikrein has been known to be stored in
secretory vesicles in the rat (Valdes et aI., 1996). Amount of kallikrein stored may
dictate the amount of mRNA expressed for kallikrein. Once kallikrein is released
from secretory vesicles, more mRNA needs to be translated into kallikrein.
Kallikrein mRNA was also detected in conceptuses that were large spherical and
filamentous. If the conceptus translates kallikrein mRNA, it may further regulate
actions occurring on the uterine surface.
Presence of kallikrein may function to cleave lalH4, allowing for
attachment of the porcine conceptus. Besides cleaving lalH4, kallikrein has been
known to act on other substrates including IGFBPs (Cohen et aI., 1992) and
kininogen (Bhoola et aI., 1992). Increase in kallikrein activity could also playa
role in regulating IGF activity within the porcine uterine lumen. Increased
amounts of IGF are present on day 12 of pregnancy (Simmen et aI., 1989), and
regulated by IGFBPs (see Simmen et aI., 1995). Several investigators (Cohen et
aI., 1992; Rajah et aI., 1996) have shown in other species and other tissues that
kallikrein family members cleave IGFBP to increase local amounts of IGF.
Recently, Lee et al. (1998) demonstrated that a serine protease in pregnant UTF
was responsible for IGFBP cleavage in the uterine lumen. Aprotinin, a serine
protease inhibitor, negated all IGFBP cleavage, but when a specific inhibitor for
plasminogen activator was added, IGFBP cleavage remained (Lee et al. t 1998).
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There is a possibility that kallikrein acts to cleave IGFBP in the porcine uterine
lumen. A straightforward experiment of measuring IGF (via RIA) and IGFBP
(ligand blots subjected to [125I]-labeled IGF-I) prior to addition of kallikrein to
cyclic and pregnant UTF, with IGF and IGFBP measured again after incubation
would determine if this hypothesis is correct. IGF liberation is likely to add in
further conceptus growth and development (see Simmen et aI., 1995).
Furthermore, addition of the kallikrein inhibitor, cyclohexylacetyl-phe-arg-ser-val-
gin amide, would provide evidence that the cleavage detected above is
specifically the proteolytic action of kallikrein.
Estrogen directed events that occur during the time of conceptus
elongation and attachment, seem to mirror events that occur during a time of
inflammation, trauma and tissue damage (Clements et aI., 1997). An
inflammatory response can be characterized by vasodilation, vascular
permeability, edema, and pain. The kallikrein-kininogen-kinin (K-K-K) system is
active at the site of inflammation (Bhoola et aI., 1992). At the site of injury, it is
typical to find mast cell activation, neutrophil invasion, as well as involvement of
cytokines, prostaglandins and growth factors with the kallikrein-kininogen-kinin
system (see Shoola et aI., 1992).
Present research detected LMW kininogen and LMW kininogen gene
expression in porcine endometrium. Endometrial gene expression of LMW
kininogen did not differ throughout the estrous cycle or pregnancy. However,
there was a decrease in LMW kininogen on day 15 of pregnancy. Levels of
kininogen on day 15 of pregnancy may be lower due to increase kallikrein
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activity. With more kinins being liberated from kininogen, more biological events
could occur. Increased kinin release results in increased blood-flow and
vasopermeability (Bhoola et aI., 1992). Ford and Christenson (1979) detected an
increase in blood flow to the pregnant uterus in the pig on days 12 and 13. The
association between uterine blood flow and pregnancy maintenance was further
reported by Ford et al. (1982) where day 13 gravid horns had higher blood flow,
as well as greater estrogen concentrations than to nonpregnant horns. It has
been documented that with an increase in estrogen (Brann et aI., 199; Valdes et
aI., 1996) there is an increase in kallikrein activity, thus increased kinin release in
the rat uterus. The increase in blood flow that is seen on these critical days in the
pig, may be due to or assisted by increased kinin release. As seen in the present
study, kininogen gene expression does not change. Kallikrein may be the key
regulator of LMW kininogen function to release kinins.
Kininogen isn't just playing a passive role in the porcine uterus.
Kininogens contain a domain that inhibits the proteolytic factor, cathepsin L
(Coleman, 1996; Schmaier, 1997). Geisert et al. (1997) demonstrated an
increase of cathepsin L activity on day 15 of pregnancy, the same day LMW
kininogen levels decline (this study). The increase that Geisert et al (1997)
documented may be due to kallikrein depleting its inhibitor, LMW kininogen.
The kinins that are released from endometrial sources may be acting with
the conceptus to further potentiate the physiologic processes occurring.
Bradykinin has been shown to stimulate IL-6 and IL-8 secretion from human
decidua derived cells (Rehbock et aI., 1997). Mathialagan et al. (1992) indicated
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that IL-6 is secreted from porcine conceptuses between day 13-17. Furthermore,
IL-6 upregulates Ial heavy chains -1, -2, and -3 which contain a von Willibrand
domain. Therefore, it is possible that kallikrein cleaves LMW kininogen, releasing
bradykinin on day 12, which binds to kinin P2 receptors on the conceptus (Allen et
aI., 1998) I to stimulate IL-6 release from porcine conceptuses to upregulate lal
members for conceptus attachment to the uterine epithelial surface.
What may have started as a simple inquiry to determine if kallikrein
cleaves lalH4, has turned out to be the discovery of a potent biological system
present in the porcine uterus. The effects and potential of the K-K-K system are
innumerable. The processes that are known to occur during this critical state of
pregnancy only add strength to the argument that the K-K-K system is active in
the porcine uterus and may serve to function during conceptus elongation and
attachment.
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Microconcentration Using Centricon 10
1. Add 2 ml of sample to the sample reservoir of Centricon 10
microconcentrator inserted into a filter cup. Cover the sample reservoir
with Parafilm.
2. Place the concentrators in the Sorval! RC-58 Refrigerated Superspeed
Centrifuge SM-24 rotor (fixed angle 280) in either the inner or outer row.
Spin for 1 hour at 6500 rpm for the inner row or 6000 rpm for 'the outer row
(1000-5000 x g).
3. Repeat steps 1 and 2 (for total of 4 ml sample concentrated).
4. Place the retentate cup over the sample reservoir and discard the filtrate
cup.
5. Invert the unit and spin for 2 minutes at 3000 rpm for the inner row or 2500
rpm for the inner row (300-1000 x g)
6. Cap the retentate and store at -aOoC or continue immediately with the
Lowry Assay.
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Lowry Protein Assay
Samplel Standards Preparation
• Uterine f1ushings and explant culture media should be concentrated prior to
doing the Lowry to ensure good readings.
• All samples and standards are prepared on ice in 13 x 100 mm disposable
tubes.
• Samples should be done in triplicate with volumes at 1 IJ,I, 3 J..LI and 5 J..LI. Use
Millipore water to bring to a final volume of 1 ml.
• Standards are prepared using BSA solution (1 mg/ml). 5 standard
concentrations with 2 tubes each are prepared. The standard volume is
brought to a final volume of 1 ml with Millipore water.
20 J..Lg BSA 20 J..LI BSA + 980 J..L1 H20
40 J..Lg BSA 40 J..LI BSA + 960 J..LI H20
80 J..Lg BSA 80 J..LI BSA + 920 J..LI H20
100 J..Lg BSA 100 JlI BSA + 900 J..LI H20
200 J..Lg BSA 200 J..LI BSA + 800 J..LI H20
A blank is prepared using 1 ml Millipore water.
Lowry C Solution Preparation
Lowry A = 2% Na2C03 in 0.1 M NaOH
Lowry B =1% CUS04 + 2% NaKTartarate mixed 1: 1
Lowry C = Lowry A + Lowry B mixed 50: 1
Prepare Lowry C just prior to use and use at room temperature
Procedure
Remove sample and standard tubes from the ice. Add 5 ml of Lowry C to each
tube using a repeat pipetter. Allow tubes to sit at room temperature for 10
minutes.
Add 0.5 ml of 1 N Phenol Reagent to each tube using the Oxford bottle pipettor.
Cover each tube with Parafilm and mix immediately after adding Phenol. Allow
tubes to sit for 30 minutes at room temperature. Read absorbance using the
Beckman DU-64 spectrophotometer at 750 nm visible Iig,ht.
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Solutions
0.1N NaOH
16.0 9 NaOH. as to 4 liters with Millipore water.
2% Na2C03 in 0.1 N NaOH
81.63 9 Na2C03, as to 4 liters with 0.1 N NaOH
1% CUS04
1.01 9 CUS04, as to 100 ml with Millipore water.
2% NKC4H40 e"4HzQ
2.04 9 NaKTartarate, as to 100 ml with Millipore water.
1N Phenol Reagent
Dilute 2N stock solution 1:1 with Millipore water.
BSA. 1mglml
100 mg BSA as to 100 ml with Millipore water.
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10 Acrylamide Gel Electrophoresis Mini-Gel
Gels can be poured up to 24 hours before needed. Remove solutions 7, 8, and
11 from the refrigerator and allow them to reach room temperature (aliquot out
amount needed to save time). Assemble two gel sandwiches. Mark the glass with
a Sharpie 5.5 em from the bottom of the plate. Wear gloves when handling
acrylamide.
For 2 gels
Running gel
1. Mix the following in a 50 ml flask:
Acrylamide stock -Solution 7
Running Buffer B -Solution 8
20% SOS -Solution 10
dH20
12.5% Gel
7.81 ml
4.72 ml
94.5 III
3.66ml
2. Add 2.5 ml ammonium persulfate (APS) (0.14 gl50 ml dH20) quickly and swirl
the flask to mix thoroughly. Pour the mixture into a 20 cc syringe.
3. Using a 20 gauge needle, pour to the 5.5 cm mark.
4. Overlay with 0.1 % SOS.
5. Allow acrylamide solution to polymerize for -30 minutes.
Stacking Gel
1. Mix the following in a 25 ml flask:
Acrylamide stock -Solution 7
Stacking Gel Buffer E -Solution 11
20% 80S -:-Solution 10
dH20
1.2 ml
1.0 ml
40 ~I
4.05ml
2. Blot the running gel with Kimwipes until dry.
3. Quickly add 5 J.11 TEMEO and 1.75 ml APS to the flask and swirl to mix
thoroughly. Pour mixture into a 10 cc syringe.
4. Using a 20 gauge needle, pour to 0.25 cm below the top of the plates.
5. Carefully insert the comb without introducing air bubbles.
6. Allow the gel solution to polymerize for -30 minutes.
7. Prepare 500 ml electrophoresis buffer:
1.5 g Tris; 7.2 g glycine; 0.5 g SOS; QS to 500m!.
8. Slowly remove the combs from the gels by gently pulling the comb straight
up.
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9. Rinse the wells with dH20 using a tuberculin syringe. Suck out and replace
with electrophoresis buffer.
10.Assemble the upper buffer chamber and lower it into the lower buffer
chamber. Fill the upper buffer chamber with electrophores'is buffer and check
for leaks. Pour the remaining solution into the lower chamber. Let gels sit for
2 hours prior to use. Gels can stand overnight.
Sample Preparation
1. Prepare Sample Buffer (SOS Reducing Buffer) the same day of use.
Millipore water
0.5 M Tris-Hel pH 6.8
Glycerol
10% (wlv) 50S
~-mercaptoethanol
0.1 % (w/v) Bromophenol Blue
4.0ml
1.0 ml
0.8 ml
1.6ml
0.4 ml
0.2ml
2. Prepare samples. I loaded SO ~g of total protein (as determined by Lowry) SO
~g of sample is brought to a final volume of 15 ~I and then 15 J.l1 of sample
buffer for a total volume of 30 ~I to add to each well.
3. Using Low range biotinylated standard (from BioRad); add 7.5 ~I standard +
22.5 ~I sample buffer.
4. Denature the samples and standard for 5 minutes over steam.
5. Immediately place in ice after denaturing.
6. Pulse down samples. Load into wells using microcapiUary pipet tips. Load 10
~I of standard to each gel. Load all 30 ~I of sample **Volume of sample
added depends on comb size-consult BioRad book for more information.
Electrophoresis
1. Attach the lid to the lower buffer chamber and connect it to the power supply
(red to red; black to black in the same channel).
2. Set the power supply at constant current. Run at 30 mA for 5 minutes until the
dye reaches the running gel. Then increase the mA to 40. let migrate until
the dye is -1 cm from the bottom of the gel. Usually takes about 65 minutes.
SOLUTIONS
Running Gel Acrylamide (solution 7)
150.0 g acrylamide
4.0 9 bis acrylamide (N, N'-Methylene-bis-acrylamide)
Bring to 500ml with dH20. Filter. Degas. Store in dark bottle in refrigerator.
Warm to room temp before use.
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Running Buffer B (solution 8) pH 8.8 - 9
90.5 g Tris
1.6 ml TEMED
Bring to 200 ml with dH20. Adjust to pH to 8.8 with about 250 ml of 1N HCI.
Adjust volume to SOOml. Filter. Degas. Store at 4°C.
20% SDS (solution 10)
10.0 g SDS
Bring volume to 50 ml with dH200
Stacking Gel Buffer pH6.6 - 6.8
29.9 9 Tris
203ml TEMED
Bring to 200 ml with dH200 Adjust pH to 608 with about 240 ml of 1N HCI.
Adjust volume to 500 ml. Filter. Degas. Store at 4°C.
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Western Blot Analysis
1. After electrophoresis, remove gel from glass plates by gently prying off the
top glass with a spacer. Cut off the stacking gel and dispose. Nick the left
hand comer (where standards are) and place gels into transfer buffer on a
rocking platform for 15-20 minutes.
2. While the gel is in the transfer buffer, prepare the PVDF membrane by
soaking it in:
a) Methanol, 1-3 seconds
b) Millipore water, 1-2 minutes
c) Transfer buffer, 2 minutes
Do not touch the membrane with ungloved hand~!! Do not allow the
membrane to dry out at any time after it is hydrated!
3. Prepare the transfer unit on the semi-dry electroblotting apparatus. Place the
sandwich together on the anode base as follows:
a) 1 sheet (6 cm x 8.5 cm) 3MM paper soaked in anode buffer 1
b) 2 sheets (6 cm x 8.5 cm) 3MM paper soaked in anode buffer 2
c) PVDF membrane (6 cm x 8.5 cm) soaked in transfer buffer
d) Gel soaked in transfer buffer
e) 3 sheets 3MM paper (6 cm x 8.5 em) soaked in cathode buffer
a-e equals one trans-unit. Repeat for second gel. Place adjacent to first
sandwich when electroblotting. The sandwich should be stacked evenly
with no air bubbles!
4. Place on lid (cathode) on top of the sandwiches. Loosely attach screws to
prevent desiccation.
5. Electroblot for 35 minutes at 150 rnA (constant current) for 2 sandwiches.
Immunostaining
*Both kallikrein and kininogen antibodies were used in the same fashion, but with
varying amounts of antibody added-see details below. AU amounts are for 2
membranes.
1. After electroblotting, immerse the membranes in TBS for 2 minutes. Place
gels in gel fixative overnight. Stain the next day with Coomassie blue for 2
hours then destain.
2. Pour off the TBs and add 60 ml of the first blocking solution (3% gelatin in
TBS) Incubate for 1 hour.
3. Wash the membrane in nBS one time for 10 minutes.
4. Pour off the nBS and add the first antibody solution. (Kallikrein= 250 JlI
Ab/50 ml Ab buffer; Kininogen= 50 JlI Ab in 50 ml Ab buffer). Let incubate
overnight.
5. Wash the membrane in TTBS three times for five minutes each.
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6. Pour off the nBS and add the second antibody solution. Incubate for 2
hours.
7. During the 2nd Ab incubation, measure 66 ml of HRP color development buffer
and allow it to reach room temperature. Thaw and measure 13.33 ml of HRP
color reagent A and protect from light.
8. Wash the membranes in nBS two times for 5 minutes each.
9. Wash the membranes in TBS two times for 5 minutes each.
10. Pout off the TBS and add the color development solution. Color development
incubation should last about 15 minutes. Cover to prevent fading.
11. Pour color development solution into waste bottle. Wash with Millipore water.
12. Scan membranes. Store in water at 4°C and protect from light.
SOLUTIONS
Transfer Buffer
25mM Tris, 192 mM glycine in 15% (v/v) methanol; pH 8.2-8.3
For 2 membranes: 400 ml containing 1.21 g Tris, 5.77 g Glycine.
Anode Buffer 1
0.3 M Tris in 10% (vlv) MeOH; pH 10.4
200 ml contains 7.27 9 Tris
Anode Buffer 2
0.025M Tris in 10% (v/v) MeOH; pH 10.4
200 ml contains 0.61 g Tris
Cathode Buffer
0.025M Tris, 40 mM glycine in 20% (v/v) MeOH; pH 9.4
200 ml contains 0.61 g Tris , 0.60 g glycine
Tris-buffered saline (T8S)
20 mM Tris, 500mM NaCI; pH 7.5
For 2 membranes, 800 ml contains 1.94 g Tris, 23.38 g NaCI
Wash Solution (TIBS)
20mM Tris, 500 mM NaCl, 0.05% Tween-20, pH 7.5 .
For 2 membranes, 500ml TBS with 250 ~I Tween-20
First Blocking Solution
3% gelatin in TBS; heat to dissolve (not over 65°C)
For 2 membranes, 60 ml TBS contains 1.86 g gelatin
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Antibody Buffer
1% gelatin in TIBS
For 2 membranes, 120 ml TIBS contains 1.21 g gelatin
First Antibody Solution
For 2 membranes:
Kallikrein-250 III Ab in 50 ml Antibody buffer
Kininogen-50 III Ab in 50 ml Antibody buffer
Second Antibody Solution
For 2 membranes:
20 III Goat Anti-Rabbit IgG HRP Conjugate (stored at 4°C),
20 III avidin HRP conjugate (stored at 4°C), in 60 ml antibody 'buffer
Color Development Solution for Horseradish Peroxidase
For 2 membranes:
66 ml HRP color development (or Tris) at room temp, 200 01 HRP color reagent
buffer B (3% H202), 13.33 ml HRP color reagent a (0.3% 4-chloro-1-naphthol in
diethylene glycol) at rm temp. Prepare just before use.
Coomassie Staining Procedure
1. Fix gels in 7% acetic acid and 40% EtOH overnight.
2. Coomassie blue stain:
1.25 9 Coomassie blue in 400 ml 95% EtOH, stir several hours then
add: 70 ml cone. acetic acid
530 ml distilled water
Filter with filter paper.
3. Stain gel for minimum of 2 hours at rm temp.
4. Destain gel in 7% acetic acid and 10% EtOH. Will need several changes.
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Kallikrein Enzyme Assay
Solutions:
0.1 M Tris-HCI buffer containing 0.15 M NaC!; pH 8
1.58 g Tris-HCI
0.88 g NaCI
pH to 8; as to 100 ml -Filter using 2 Ilm filter.
Substrate
Pro-Phe-Arg 7-Amido-4-Methyl-Coumarin
From Sigma Chemicals (P-9273)
Stock solution: -5 mg/1 ml buffer= -8.68 mM
Working solution: 10x dilution
50 III stock:450 III buffer
Standard
7-Amino-4-methyl-Coumarin
From Sigma Chemicals (A-9881)
Stock solution: 1 mgl 1 ml DMSO
Working solution: Dilute SOx
100 III stock:4.9 ml buffer
Instructions to turn on Fluorescent Spectrophotometer
1. Turn on water bath
2. Turn on main power source
3. Make sure the fan is plugged in
4. Turn lamp on (button on power source)
5. Turn recorder on
6. Turn spec on
7. Set excitation wavelength at 370; slit width 5
8. Set emission wavelength at 460; slit width 5
9. Set on data; ratio mode
Standard Curve:
Mix in microfuge tube and vortex for proper mixing
Standard curve consists of 5 points. Add 4 Ill, 9.8 Ill, 15 Ill, 20 III and 32 III
separately to 250 ml buffer for each point. Record wavelength. After recorder
wavelength for the 32 III point, set recorder range by dividing the wavelength by
8. Type this number into spec and then use chart recorder to record the
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wavelength. This is needed to for further calculations (gives mMlmV) Record the
setting of mV/min on chart recorder that you have selected.
Samples
All samples and substrate are kept on ice until assayed.
Run each sample in duplicate. Add 10 ~I of substrate and 200 ~I of buffer in a 1.5
~I bullet tube. Add 40 ~I of sample Vortex and immediately put into spec for
reading. Record using chart recorder at 6 em/min. Let assay run for at least one
minute.
To calculate specific activity, divide mMlmV by the total protein concentration.
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Reminders of General Procedures for Polymerase Chain Reaction (PCR)
For each new primer that is designed, an optimization must be done. The amount
of Taq polymerase stays constant for every reaction at 0.175 III I tube. The total
volume in each tube is 25 Ill. 2.5 Fli of 10x Buffer is added to each tube. Add
other ingredients as indicated in the below table. as to 25 III with PCR water.
Lane Primer (5 j.LM stock) dNTPs (10 mM stock) 10 x MgCI
1 0.5 III 0.5 Ill' 1.251.11
2 0.5 0.5 2.50
3 0.5 0.5 3.75
4 0.5 1.0 1.25
5 0.5 1.0 2.50
6 0.5 1.0 3.75
7 1.5 0.5 1.25
8 1.5 0.5 2.50
9 1.5 0.5 3.75
10 1.5 1.0 1.25
11 1.5 1.0 2.50
12 1.5 1.0 3.75
13 2.5 0.5 1.25
14 2.5 0.5 2.50
15 2.5 0.5 3.75
16 2.5 1.0 1.25
17 2.5 1'.0 2.50
18 2.5 1.0 3.75
After optimal conditions are found, proceed with "regular" PCR.
Fill out a PCR reaction sheet prior to each reaction.
Prepare Master Mix (MM). MM includes all ingredients except cDNA.
A negative control should be included in each PCR reaction to check for
contamination. Negative control is prepared by adding PCR water in place of
cDNA. A genomic sample can be added to test for DNA contamination in cDNA.
The work area, peR pipettors, and tube opener should be cleaned with 10%
Clorox prior to use.
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Only tips and tubes designated for PCR use, should be used.
Throughout the entire procedure, all ingredients and tubes should be kept on ice.
Taq should remain at -20°C until use.
25 ml of PCR oil should be added to the top of every tube prior to placing tubes
into thermal cycler to prevent desiccation.
PCR requires a hot start. Allow heat block to reach 85°C before placing tubes in
thermal cycler.
Store PCR products at 4°C until run on agarose gel.
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